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Blood glucose homeostasis is the processes of bringing blood glucose concentration within a normal 
blood glucose range through effective and complex contribution of different body organs, tissues, 
hormones, enzymes, and others in a human body when there is an imbalance condition happened 
between glucose oxidation as energy source for the body and carbohydrate intake as a daily diet, 
glucose and fat serve as a fuel to produce energy for the human body. During the process of blood 
glucose homeostasis, excess glucose that are not used by the body gets transported and stored as 
glycogen in liver and muscle tissues by the help of hormone insulin, but further conversion of 
glucose to fat happens when muscle glucose storage is full. Excess fat in the body due to imbalance 
glucose and fat intake induces communication failure between the hormone insulin and insulin 
induced glucose transporter (GLUT4) on muscle and adipose tissue cells during glucose oxidation, 
hormone insulin failure to produce enough glucose transporter has given name of a disease insulin 
resistance (Type II NIDDM). Unsuccessful glucose oxidation on adipose and muscle tissue let blood 
glucose concentration to be above the normal range and in lifelong develops complication on 
pancreas to be totally unable to produce insulin (Type I IDDM), heart, kidney, eye, and the others. 
Given that the human anatomy and physiology are an integrated complex system of organs, cells, 
hormones, enzymes and others, a System Dynamics approach is a relevant and effective way to 
investigate the underlying causes and dynamic mechanisms influencing insulin resistance and to 
identify and test feasible solutions. By modelling and simulating the represented organ and system in 
the blood glucose homeostasis process, these possible solutions targeted on weight reduction (BMI) 
specifically excess fat in the body. Weight reduction as a treatment of insulin resistance gives a 
significant change on glucose oxidation in adipose tissue, glucose oxidation in muscle tissue, blood 
glucose concentration and unnecessary production of hormone insulin in the body. Therefore, a 
planned daily diet, using body fat as direct source of energy and as a source of blood glucose in the 
process of gluconeogenesis, and daily physical activity that contributes to energy expenditure; are the 
most effective strategies found in this study to reach body weight (BMI) goal since excess fat hinders 
glucose oxidation in the muscle and adipose tissue. 
The System Dynamics simulation model presented in this thesis can contribute to a better 
understanding of the factors driving increasing trends of serious diseases, such as diabetes mellitus, 
across populations and detect and test in future scenarios, potential prevention and treatment policies 
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Chapter 1 .  Introduction 
1.1. Background. 
The anatomy and physiology of a human being is described as one of the widest and complex 
systems which shows the structure of the human organ from the small level to the biggest including 
its function to perform a specific task (Cobelli & Carson, 2019), the organs have its own main 
function or helping the other organs function either locally or in a general system level to keep alive 
the life of the human beings (Wingerd & Taylor, 2020). 
Organs and the system developed based on the organs that are found in human body works 
dependently to each other, this interconnection is grouped in a system level like lymphatic system, 
nervous system, urinary system, blood circulatory system, skeletal system, muscular system, 
endocrine system, vascular system, system in the respiratory organ, system in the digestive organ, 
and system in the reproductive organ (Cohen & Hull, 2020). All the systems that are described above 
working together according to both the internal and external factors to regulate the parameters found 
in the human body through metabolism (Castillo‐Armengol et al., 2019; Solomon, 2015), 
Homeostasis is one of the mechanisms that keep the parameters within a normal range when 
unbalanced intake and usage of glucose by the organs to benefit the whole organs in the body to keep 
going normal and to provide its service effectively (Coad et al., 2019).  
Studies showed and defined blood glucose homeostasis as holding the parameter blood glucose 
concentration from 3.9-7.1 mmol/l (Shah & Wondisford, 2020), during any internal or external  
glucose related influences are applied on human body. For instance, after a meal blood glucose level 
rise to be above the normal limit (hyperglycemia), then the body organizes all the responsible 
systems to transport excess glucose to be stored as glycogen (Adeva-Andany et al., 2016) and 
convert  excess  glucose to fat (Fialkowski Revilla et al., 2018), in the other way during 
starvation(fasting) or when the blood glucose level is below (hypoglycemia) our body reuses the 
stored glucose by converting glycogen to glucose or by converting noncarbohydrate (proteins and 
fats) to glucose in order to increase blood glucose concentration level by using different hormones 
and enzymes in the body (Kim et al., 2020).  
Organs and organ-based systems that are found in human body needs sufficient amount of energy to 
accomplish their own function from minimum which is basal up to the highest energy demanding 
activity in  our daily life cycle (Laughlin, 2001). The fundamental nutrients that are important and 
useful as a source of energy for our body are glucose and fats (Pang et al., 2014), glucose is a 
monosaccharide carbohydrate which can absorbed easily in the gastrointestinal tract and it is the only 
source of energy as a fuel in normal condition for  brain but brain uses ketones from fat as energy 
source when shortage of glucose happens in the body (Kroemer et al., 2018).  
Blood glucose in human body is exogenously influenced by the external factors, those factors which 
elevates or decreases the blood glucose level are the daily meal intake as an input and the physical 
status (physical activity level) from the rest state to the high energy demanding physical activity 
level as an output, but the endogenous factors regulates and brings back the extreme blood glucose 
level to the normal state by using different hormones and metabolism processes as far as blood 




1. By converting glucose to other forms of carbohydrate(glycogen) and storing in different 
organs through the process of glycogenesis to keep euglycemia from hyperglycemia.  
2. By synthesizing fat from blood glucose to keep euglycemia from hyperglycemia. 
3. By synthesizing glucose from noncarbohydrate (fats and proteins) nutrients to keep 
euglycemia from hypoglycemia through the process of gluconeogenesis.  
4. By converting the stored form of glucose (glycogen) to glucose through the process of 
glycogenolysis to keep euglycemia from hypoglycemia. 
5. By excreting excess glucose together with urine from the body by the organ Kidney. 
Basically, the relation between daily meal intake and daily utilized nutrients in the cell shows how 
blood glucose homeostasis goes in the human body. All the physiological processes that are involved 
in blood glucose homeostasis forced to have a dynamic behavior, this dynamic behavior is 
manifested by the glucose storage and the accumulation of unnecessary fat (Sears & Perry, 2015). 
Fat accumulation in the body (adipose tissue) exposes organ cells to suffer in a disease insulin 
resistance (Donath & Shoelson, 2011; Jensen et al., 2011; Sears & Perry, 2015) and for a long run, 
probability  of facing further complications due to insulin resistance is high (Kahn, 1998). Insulin 
resistance defined as the falling of organ cells response (tissues especially muscle and adipose) to  
insulin during glucose uptake, insulin  is an endocrine hormone secreted by pancreas β-cells 
(Yaribeygi et al., 2019). 
Since the blood glucose level relies on both internal and external factors, its variation detected by the 
human body organ pancreases, the hormones that are secreted by the alpha and beta cells of the 
pancreases to lower or increase the blood glucose level are Insulin and glucagon (Gowd et al., 2017). 
The hormones insulin and glucagon applied on the conversion of glucose by up taking glucose or by 
releasing glucose according to the blood glucose level but on the other side this hormone has role on 
the concentration of free fatty acids in the blood and triglycerides in the adipose tissue since both 
free fatty acids and triglycerides are products for each other through active interventions of the 
hormones Insulin and Glucagon (Fujikawa, 2021). According to Americans diabetic association lack 
of hormones that are involved in the glucose conversion process are the main possible cause for a 
diseases Diabetics Mellitus (Association, 2014). 
As far as blood glucose homeostasis is concerned, blood glucose concentration varies with in the 
limit for normal healthy persons. In this thesis, the author is using a healthy person’s blood glucose 
concentration as a reference, the study was applied on twenty-four nondiabetic adult volunteers 
living in normal condition by using 50-gram glucose intake as a diet three times a day for one day 
duration (Figure 1-1.) (Freckmann et al., 2007). 
 




1.2. History and Types of Diabetics Mellitus. 
The name Diabetics Mellitus is derived from a Greek word having a meaning of “pass through” for 
Diabetes and “sweet” for mellitus, this implies the meaning resembles to the availability of glucose 
in urine (Lakhtakia, 2013; Zajac et al., 2010).  
Out of 10 popular leading to death diseases in the world, Diabetes Mellitus is included in the group  
and  it is also one of the top 4 non communicable diseases that has complications in human body 
which can be an immediate cause for  mortality (Oguntibeju, 2019). Diabetes Mellitus is very well-
known health problem progressing every year (Glovaci et al., 2019). 
Metabolic disorders specifically Diabetics mellitus is manifested by the increasing of blood glucose 
concentration (hyperglycemia) relative to the normal range, the possible cause of diabetic’s mellitus 
to attain hyperglycemia is caused by interruption of insulin production on pancreas beta cell, cell 
response reduction for insulin and due to the existence of both problems at the same time (Yaribeygi 
et al., 2019).  
Hyperglycemia  has a long-term complication on human organs, gradual loss of organ functionality 
is a complication of diabetic induced hyperglycemia which is more observable on the organs heart, 
kidney, eye and the others (Ahmad et al., 2021). 
Enormous research classified Diabetic Mellitus based on the problems related to Insulin action and 
Insulin production as follows. 
1.Type I (Insulin Dependent Diabetes Mellitus) is developing due to malfunction of insulin 
production on β-cells in the human organ Pancreases that leads to inadequacy of Insulin in the body 
(Paschou et al., 2018). 
2.Type II (Non-Insulin Dependent Diabetes Mellitus) is developing due to decreasing response of 
cells to hormone insulin (insensitive to insulin) but sometimes decreasing of insulin production and 
less sensitivity of cells to insulin happens together (Han Wu et al., 2018). 
3.Gestetional Diabetes Mellitus  
Repeated increasing of morning blood glucose level during pregnancy diagnoses Gestational 
diabetes mellitus, early treatment by doing daily activity can prevent further complication (McIntyre 
et al., 2019).Diseases related to Cardiovascular and diabetes mellitus are complications for the 
mother and complications on the infant happens at birth, history of diabetes in the family and obesity 









1.3. Problem Identification Statement. 
 Insulin Resistance.  
Regular homeostasis effectiveness assures the health status of human body (Abdel-Hamid, 2003), 
any abnormal weight change especially fat in the body exposes human beings to fall on a risk of 
diseases (Manuel-y-Keenoy & Perez-Gallardo, 2012). 
Insulin resistance and other cardiovascular diseases are considered as epidemic in the world due to 
its annual increasing rate of new patients, insulin resistance is one of the outcomes of a disease 
developed due to obesity (Ghadimi et al., 2021; Huaizhu Wu & Ballantyne, 2020). 
Glucose up taking during the process of metabolism in the cell needs hormone insulin as a 
stimulator, the action of the hormone insulin in human body especially muscle and adipose tissue cell 
of insulin stimulated glucose transporter GLUT4 varies according to the level of cell tissue 
inflammation induced by the excess accumulated fat on the process of insulin signaling (Zatterale et 
al., 2020).  
This abnormal communication between stimulator insulin and the expected amount of  glucose to be 
used by the cell leads the blood glucose concentration keep higher and pancreas forced to secrete 
more insulin to metabolize glucose in the cell, this continuous request of insulin 
production(hyperinsulinemia) from beta cells of the pancreas due to hyperglycemia overload the beta 
cells and beta cells gets production imbalance then the organ will face insulin production 
problem(diabetics mellitus) in addition to glucose utilization problem (Schinner et al., 2005). 
Gradual uprising of diabetic's mellitus complication appears as macrovascular diseases by affecting 
the heart and as microvascular disease by affecting kidney, eye, and nerve system (J. B. Cole & 
Florez, 2020). 
In general, Insulin resistance refers resisting or decreasing glucose uptake of muscle and adipose 
tissue cells in response to the hormone insulin when the human body is under the process of 
anabolism and catabolism due to less number production of insulin stimulated glucose transporter 
(GLUT4) in a single cell. This implies as the number of glucose transporters decreases relative to the 
normal production, enough glucose will not reach inside the cell to be oxidized. 
Additional scientific research show that investigation focuses on the cause-and-effect relation 
between insulin resistance and diseases developed because of insulin resistance as follows. 
Unplanned diet habit as an energy intake without taking physical activity as energy expenditure into 
consideration worsen the situation in a long-time basis due to overfeeding and conversion of unused 
carbohydrates to fat in the body in addition to our daily fat intake (Fialkowski Revilla et al., 2018; 
Houghton et al., 2019), this indicates the major excess fat accumulation in adipose tissue found in 
visceral and muscle. 
As a result of increasing the number of adipocytes due to excess accumulation of fat in the body the 
hormone adipokines production will increase (Zorena et al., 2020), rising adipokines in the body 
together with fat induced  low density lipoproteins and reduction of fat induced  high density 
lipoproteins become the dominant cause for the complications developed on cardiovascular and 
metabolism (Su & Peng, 2020). 
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Studies for the past decades shows that the excess accumulation of fat from direct diet of fat and 
ingestion as carbohydrate through conversion to fat has effect on our body mass index, BMI 
classified in a group of normal, overweight, and Obese based on body mass index. Normal body 
mass index is less than 25 kg/m2 and Obese group shows BMI is greater than 30 kg/m2 whereas 
overweight is in between 25 and 30 kg/m2 (Hasan et al., 2021; Martinez et al., 2017), degree of fat 
accumulated in the body in both groups of obesity and overweight has a significant factor to be a risk 
group for the development of Insulin resistance. 
In this thesis, the author is trying to take as a reference of insulin resistance in the modelling process 
as a problem which is studied on eight obese volunteers with  
                        Average BMI of 34.4 ± 1.8 kg/m2 
                       Average body weight of 102.9 ± 5.1 kg 
And with a medical history of non-insulin dependent diabetic mellitus without any health 
abnormality issues (there is no additional health problem identified during recruitment) (Henry et al., 
1986). 
 During the study on Insulin resistance patients by Henry et al. (1986), the process had separate 
phases. 
1. Preparation phase: is a period for all the voluntary to have medical 
check-up until having stable body weight, it took 2 months. 
2. Weight reduction period is the main part of the research which was 
conducted in the hospital and at home ranging from 60 to 380 days.  
Before all the volunteers following the treatment as an outpatient from home, they were admitted in 
the hospital from 10 to 40 days. 
3. Weight maintenance period is a 3-week period. 
during this research, long term morning blood sugar level was considered as one of the signs of 
Insulin resistance, blood sugar early in the morning was taken at 7:00 A.M and all the volunteers 
took 75-gram carbohydrate in liquid form prepared for this purpose then began to measure blood 
glucose level for 3 hours, the same procedure had been taken after weight reduction with good 




Figure 1-2. Blood glucose level for non-insulin dependent diabetics mellitus (Insulin Resistance) before and 
after weight reduction as a reference mode. 
 
Based on the average blood glucose concentration sample took from the voluntaries in the morning, 
the value was 14.85149 mmol/l which is too high relative to the normal human expected fasting 
blood glucose concentration level and can fulfil the requirement for Insulin resistance with fasting 
blood glucose concentration level ≥ 7.0 mmol/l (Martinez et al., 2017; Tang et al., 2019) whereas the 
initial point for the green line (7.26 mmol/l ) indicates the treatment was effective and shows a 50% 
progress on the fasting blood glucose concentration level.  
1.4. Thesis justification. 
Insulin resistance is a complex problem with many interrelated variables and interactions involved, 
that can lead to serious diseases on organs and systems such as Type I Diabetes Mellitus, 
cardiovascular, Kidney and eye. SD is a tool that allows to understand and analyses complex 
problems like this one and provides a way to test and assess interventions to reduce and prevent this 
problem.  
In this thesis, the author intends to investigate how blood glucose homeostasis can be understood by 
different stakeholders such as medical experts, health decisionmakers and the public in general, and 












1.5. Objectives of the Research 
 
Human physiology in blood glucose homeostasis process has dynamics due to the presence of natural 
interactions in and out of the cell, those normal and abnormal dynamic interactions in the body needs 
to have a detail analysis to investigate the cause for the problem, the solution as a management of the 
problem and cause and effect relation(physiology) of cells, tissues, organs, and systems in the body. 
In general, the objective of this thesis marked as follows. 
1.To explore the main underlying dynamic interactions among variables (hormone, cell, organ, and 
nutrients) and feedback processes involved during blood glucose homeostasis. 
2. To analyze dynamic effect of body hormones especially insulin on glucose metabolic process 
since less quantity (unproportionable) production of insulin in the body is an indication to the disease 
Diabetics mellitus. 
3. To study the dynamic implication of insulin resistance development in the body and to investigate 
potential management mechanisms to address insulin resistance (type 2 diabetics mellitus) due to 
excess accumulation of fat (BMI based) in the body through daily diet relative to daily activity by 



















Chapter 2 .  Literature Review 
In this chapter the author reviews blood glucose homeostasis related to Insulin resistance literature 
undertaken in system dynamic approach and other study methodologies, the ultimate goal is to get 
updated understanding on the solutions and on the main cause of insulin resistance during the 
process of blood glucose homeostasis to achieve efficient solution for the diseases and its 
complications by applying additional features during the study, making easily understandable 
physiology of blood glucose homeostasis in system dynamic approach is also included as a goal. 
Computer based automated technologies on human physiologies for the purpose of medical treatment 
is not that much developed relative to automation on the other sectors, complex system induce blood 
glucose controlling application is one of the automated technologies and insulin resistance is one of 
the cause for blood glucose to be high (Chase et al., 2019).   
Studies that are found during literature review labeled as follows. 
Model-based studies on insulin resistance. 
The model designed and studied by Pielmeier et al. (2010) concludes that understanding the amount 
and the effect of insulin in the body on insulin resistance patients by the help of models prevents the 
prevalence of excess insulin in the body, excess insulin in the body exposes the patient to fall in the 
condition of hypoglycemia. For the purpose of controlling glucose in the blood, a normal Physiology 
based compiled metabolic model studies glucose absorption in the gut and insulin action on the 
organs to see how far organs response for insulin to reach its maximum level. The compiled model 
contains endogenously influenced blood glucose dynamics, insulin, and assimilation of glucose from 
the diet. Insulin and glucose intake administered externally to control the blood glucose in addition to 
the normal anatomy and physiology. 
Systems thinking and System Dynamics literature. 
System thinking on the developed complex system is the base to analyze the behavior of the system, 
reason out how the feedback loop is part of it. Representing blood glucose homeostasis by the help of 
closed loop diagram to give insight and to have better mental model for the students about anatomy 
and physiology of blood glucose is studied by (Wellmanns & Schmiemann), feedback reasoning skill 
on the behavior of complex blood glucose level helps to investigate the cause and effect relation of 
hormones, organs and blood glucose level. Reasoning the regulatory system of feedback loop 
includes the hormones of insulin and glucagon, both hormones play its specific role on the 
conversion of glucose to glycogen and vice versa. Analyzing the feedback loop shows the dynamic 
of blood glucose during internal and external influences occur on the body, external influences 
include food as diet and glucose as a source of energy.   
Abdel-Hamid (2003) studied obesity treatment through exercise and diet by using system dynamics 
approach to get understanding on the relation between diet and exercise with weight change, weight 
change is exempted a dynamic behavior due to the systems. In the model building, the author shows 
the interdependency of hormones and different organs during the process of metabolism. Finally, the 
simulation result shows that more weight is lost due to diet than moderate exercise in a daily life due 
to exercise effect on fat mass. On the other experiment, moderate to high level exercise is more 
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effective way of reducing weight but better weight reduction is recorded by increasing carbohydrate 
portion with increasing exercise intensity.   
Modeling glucose homeostasis by using system dynamic methodology undertaken to understand the 
phenomena included in the model as organ, the study concludes that the secretion dynamic behavior 
of insulin is determined by the duration of infused glucose and further when the amount of glucose in 
the blood increases nervous system glucose utilization increases but in adipose and muscle tissue, 
insulin is the additional requirement for glucose utilization. the study also focused on to see how the 
blood glucose homeostasis goes when the connection between glucose level and insulin secretion is 
interrupted by some factors to see how diabetics looks like during less insulin production (Foster et 
al., 1973). 
The above model-based literatures do not have complete anatomy and physiology on insulin 
resistance that the author studies right now, instead the above study focuses on part of the authors 
model, relation between blood glucose and insulin can be example for the literature found during 
reviewing literature. 
Therefore, in this study, the author shows blood glucose homeostasis on the diseases of Insulin 


















Chapter 3 .  Methodology 
System dynamics (SD) is a methodology and works as a basic tool to understand the complex 
dynamic behavior developed by the structure, understanding the complex dynamic behavior favor 
the reader or the researcher to have a good insight during identifying the right problem, 
hypothesize and analyzing by the help of computer simulation to make reliable policy before 
implementation (Sterman, 2000).  
 
The research objectives in this thesis regarding excess fat induced Insulin resistance as a problem has 
given attention to answer in detail by using system dynamic approach as a relevant and optimal way 
of studying broadly blood glucose homeostasis to investigate the main cause of the problem since in 
human anatomy and physiology, blood glucose homeostasis with problems related to it like Insulin 
resistance is one of the complex systems encapsulated in human body. 
  
Using System dynamics approach to study problematic issue relies on the feedback relation in the 
system between two or more variables included in the structure, variables are directly or indirectly 
responsible for the generated dynamic behavior in a complex system since a collection of variables 
in the system are the foundation of the structure but share of variable effect on the generated 
dynamic behavior differs accordingly.   
 
Feedback relation implies that the effect of one variable as a cause for the next variable forward any 
signal to the next and receive any signal back from previously influenced variable or literally it is the 
result of action and reaction between two or more variables in a complete loop, those feedback 
relations represented by Balancing (B) and Reinforcing (R) loops (Lin et al., 2020). 
 
Dynamic behavior is developed due to the interaction of balancing and reinforcing loops in the 
system, balancing loops rises from the opposite interaction of variables in the loop whereas 
reinforcing refers transferring by amplifying received signal to the next (Mohammadi et al., 2018). 
 
According to Sterman (2000), causal loop diagrams are tools that helps to have a good image on the 
system developed by the feedback structure whereas stock and flow diagrams shows the right 
structure and mathematical relations in between, stocks are the accumulated result of the rated flow. 
A CLD aids in synthesizing key factors generating a problem and identifying the relationships 
among these factors; and is then used by stakeholders and practitioners to investigate the cause of the 
problem (El-Sayed & Galea, 2017). 
Example: figure 2-1 shows the population growth by taking birth and death into consideration, both 
reinforcing and balancing loops are developed due to the cause-and-effect relation between birth rate 
with total population and death rate with total population. 
Reinforcing loop.  
In the Figure 2-1, the arrow from birth rate to total population indicates that birth rate influences total 
population and the (+) sign indicates when birth rate increases total population also increases, and 
total population has also the same effect on birth rate back through the other arrow. Therefore, the 
relation between birth rate and total population are positive and at every cycle the number of birth 









In the figure 2-1, when total population increases death rate also increases because the arrow from 
total population to death rate is positive but when death rate increases total population decreases 
because the (-) sign indicates that there is opposite relation. Therefore, total population and death rate 
has a counteracting relation, this implies that balancing loop is developed in the system between total 
population and death rate. 
 
CLD is a straightforward way description which can introduce how the cause-and-effect relation 
goes based on the type of response on hormones, organs or in system level. In the CLD of figure 3-1, 
(+) indicates both cause and effect go in the same direction but (-) indicates cause and effect goes in 
opposite direction. 
Note. Total number of (-) in a single loop determines the feedback loop behavior, if the number of (-) 
s are even the loop becomes reinforcing but if it is odd the loop becomes balancing (Inghels, 2020). 
 
According to Abdel-Hamid (2003), human anatomy and physiology holds both reinforcing and 
balancing loops, balancing feedback loops are more dominant on the homeostasis process especially 
the effect of hormones. Missing insulin sensitivity by the organ’s attacks back the feedback systems 
and develops a consequence on other organs or systems like blood glucose concentration due to less 
capacity of glucose uptake by the cell (Chase et al., 2019). 
 
Ethics 
The increased use of computer technologies and modelling techniques addressing complex problems 
raises many ethical questions such as: What is the proper relationship between the model builder and 
the model user? Should the model builder assume professional responsibility for the result of their 
models? (Wallace, 1994), these questions were taken into account by the author during the 
development of this thesis. Ethical evaluation is important to apply on the modelling process, using 
professional guidelines to follow ethical research procedures and standards during the modelling 
work (Pruyt & Kwakkel, 2007; Saltelli, 2020).  Models’ assumptions and limitations must be 
appraised openly and honestly(Saltelli et al., 2020). Hence, this thesis provides complete model 
documentation for model replication, described all assumptions made during the modelling process, 
and defined model boundary. 
  
In this thesis, there was no primary data collection involved, therefore, ethical considerations related 







Chapter 4 .  Model description 
In this chapter the author shows the structure representing tissues, organs and systems that are 
involved in blood glucose homeostasis by using stock and flow diagram (SFD) and then theory of 
human anatomy and physiology function described in a cause-and-effect relation by using feedback 
loops on the developed CLD.  
4.1. Structure of blood glucose homeostasis by using SFD.  
Constructing well functioned model is the result of good scientific reasoning of how each organ, 
system or hormone in the body interlinked and influencing each other in a cause-and-effect relation. 
The conceptual model in figure 4-1 represents the main constructed model structure that generates a 
dynamic behavior of both problematic for insulin resistance and a normal behavior that develops 
after the treatment described in the introduction part since conceptual model helps us to easily 
understand the physiology of the organs in the body, but detail anatomy and physiology is described 
on the actual model. 
 
Figure 4-1. Conceptual model for blood glucose homeostasis. 
 
The model has 4 sectors and represented by the conceptual model on figure 4-1, the sector is 
described as follows. 
1. Blood glucose sector. 
In the actual model of blood glucose sector on figure 4-2, the main organs or tissues involved 
in the processes of metabolism are listed below. 
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Daily carbohydrate intake as an exogenous factor through the process of glucose absorption 
from GIT is followed by storing excess blood glucose in liver and muscle through the process 
of glycogenesis, excess glucose further converted to fat when muscle glycogen is full.  
 
Figure 4-2. Blood glucose sector of actual model structure. 
Converting the stored glucose(glycogen) in liver to glucose during shortage of blood glucose 
happens in the blood vessel through the process of glycogenolysis, non-carbohydrate 
nutrients (fat and protein) from the body converted to glucose through the process of 
gluconeogenesis when glycogen in the liver reduced. Kidney is involved in the process of 
blood glucose filtration and re-absorption; its rate is relay on blood glucose concentration 
level.  
Glucose utilization or oxidation on the process of glycolysis in the cell of the body is grouped 
in to four (Brain Glucose oxidation, Splanchnic organs glucose oxidation rate, adipose tissue 
glucose utilization rate and muscle glycogen burning rate), all oxidation rate on the model 
release energy for the body during the process of burning glucose. 
  
2. Hormonal Sector. 
Pancreases is the organ that detects the level of blood glucose level and produces the 
hormone insulin and glucagon accordingly, insulin is responsible to stimulate the processes 







Figure 4-3. Hormonal sector of model structure. 
Glucagon is involved on the process opposite to insulin, the process of glycogenolysis and 
gluconeogenesis are stimulated by the hormone glucagon when blood glucose level is below 
the normal level. 
3. Fat Sector 
Fat daily intake and fat from glucose are the only source of fat but total fat is the sum of both 
three (total daily fat intake, body fat and fat stored from glucose). Fat is one of the continuous 
sources of energy during body metabolism through the process of fat oxidation and fat could 
be the source of glucose through the process of gluconeogenesis when blood glucose is below 
the normal level. 
 
Excess fat found in the body through the effect of BMI controls blood glucose utilization in 





Figure 4-4. Fat sector of model structure. 
4. Energy Expenditure Sector 
Energy sector highly concerned on the amount of energy needed by the body, the amount of 
energy needed by the body relies on the weight and the daily physical activity of the body.  
Weight of the body varies every time according to the amount of fat in the body since fat uses 
as a source of energy in the body.  
 
 




Weight base hourly energy expenditure of the body uses fat and glucose as a source of 
energy, the required energy is grouped in the body in to four main tissues or organ groups 
(glycogen required by muscle, glucose required by brain, glucose required by splanchnic 
organs and glucose required by adipose tissue). 
 
4.2. Dynamic hypothesis and main feedback loops.  
In addition to the conceptual and actual model described above, the author shows how blood glucose 
concentration level influences and gets influenced by the other hormones, organs, and system in 
detail by using a CLD (See figure 4-6). 
System dynamics classified the factors that influence the dynamic behavior in to two. 
• Daily Carbohydrate intake as a meal, Daily fat intake as a meal, Physical activity 
level, Weight, and height are the exogenous factors that influences the system without 
any feedback on it (See figure 4-6). 
• Endogenously engaged variables in the model controls the system by influencing its 
next parameter in the loop and influenced back the system by another parameter, 
endogenous parameters in this model explained in detail based on the loop grouped in 
the CLD of figure 4-6. 
  4.2.1. External source influencing the physiology of the body (Exogenous Factors).  
   I. Carbohydrate. 
Carbohydrate in human daily diet covers 50% of nutrients needed for daily energy requirement since 
it is the main source of energy relative to proteins and fat (Shan et al., 2020). 
Carbohydrate in the form of glucose taken as a diet in human body to achieve daily need for the 
organ cells, brain and some of the cells found in human body uses glucose as source of energy in 
normal condition since glucose has a capacity to pass blood brain barrier to reach the cells of brain 
(Koepsell, 2020). 
Carbohydrate is water soluble containing elements carbon, hydrogen, and oxygen but the ratio varies 
according to the type of carbohydrate in the subgroup, the carbohydrate group that our body uses as a 
source of energy contains 6 elements of carbon,12 elements of hydrogen and 6 elements of oxygen. 
as a source (Stick & Williams, 2010). 
Carbohydrate is  classified in a subgroup of simple and complex based on how the structure of each 
element is bind together to get separately as an energy source, simple carbohydrates have a behavior 
of releasing quickly during digestion whereas slowly digestible carbohydrates are complex but both 
of them synthesized in animals and plants (Siva et al., 2019). 
Based on the contents in, carbohydrate classified as monosaccharides, disaccharides and 
polysaccharides (L. A. Cole & Kramer, 2015). Simple carbohydrates are the group name given for 
both monosaccharides and disaccharides, monosaccharides are Glucose, Fructose and Galactose but 
Maltose, Lactose and Sucrose are simple disaccharides carbohydrates (Blanco & Blanco, 2017). 
Polysaccharides under the complex carbohydrates, are formed by making a long chain of 
monosaccharides, Starch and Glycogen as a Polysaccharides can be synthesized from 
monosaccharides on the process of dehydration (Muhamad et al., 2017).  
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Prior to assimilation of carbohydrate from GIT, disaccharides and polysaccharides need to be 
converted to monosaccharide through the process of digestion, digestion of carbohydrates starting 
from the mouse by the help of salivary amylase (Lunn & Buttriss, 2007). 
Stomach is the organ next to esophagus that chemical reaction and digestion are performed due to 
production of different enzymes based on the type of food intake available in the stomach, the acidity  
in the stomach deactivates the action of salivary amylase through the process of chyme formation 
prior to digestion in the small intestine, in the small intestine by using hormones pancreatic amylase, 
maltase and sucrase involved in the process of converting polysaccharides and disaccharides to 
monosaccharides where monosaccharides are absorbable form of carbohydrates at intestinal villi 
(Walther et al., 2019). 
Monosaccharides from the small intestine absorbed from the intestine and transported in to the blood 
circulation by sodium dependent transporters(SGLT1) and other non-sodium dependent transporters 
(GLUT 2 and GLUT 5) (Hinsberger & Sandhu, 2004). 
The importance of glucose as a source of energy for most cells in the body required to have a 
transporter that helps glucose to be easily reachable when there is in need of it, Sodium glucose 
linked transporters(SGLTS) and Glucose transporters (GLUT) are the main carrier of glucose, 
Glucose transporters described in detail as follows in table 7-1(Appendix) since the cause of insulin 
resistance is Physiological communication failure between hormone insulin through the insulin 
receptor and availability of GLUT4 on the wall of the cell (Navale & Paranjape, 2016). 
   II. Fat daily intake. 
According to Hamosh (2020), Fat in human beings is essential for body growth, development, and an 
energy source. Gastric lipase is the second enzyme secreted in stomach next to Lingual lipase which 
is produced in the mouth that emulsifies and helps digestion of fat, digestion of fat helps to isolate 
fats in the form of fatty acids and watery compounds.  
lipids are the complex form of fats and fatty acids are the simplest form (Zárate et al., 2017).  
Further digestion and absorption of lipids in the small intestine supported by the hormone produced 
by liver and stored in a gallbladder. Pancreatic lipase is an enzyme synthesized in the pancreases and 
involved in the conversion of triglycerides into fatty acids and glycerol’s in small intestine, 
absorption of digested fat in the small intestine through microvilli (Goodman, 2010). 
The assimilated fat products used as energy source during energy in need but excess fat available in 
the blood vessel transported to adipose tissue for storage, triglycerides in the adipose tissue convert 
back to fatty acids and glycerol during energy need as fat (fatty acids) and can also be the source 
during gluconeogenesis(glycerol).  
Absorption rate and the process of making free fatty acids and monoglycerides ready for absorption 
in the GIT is controlled by the availability of digestive enzymes, pancreatic and gastric lipase has a 






Figure 4-6. Adult blood glucose homeostasis CLD, green color is for hormonal sector and the black connector 
shows the relation of BMI on adipose and muscle glucose utilization. 
. 
Table 4-1. Assigned loops from the CLD with description. 
No Loop Given name of the Loop Description 
1 B1 Kidney glucose 
filtration. 
Glucose involved on the process of filtration by Kidney. 
2 R1 Kidney glucose 
reabsorption. 
Glucose reabsorption in the kidney during filtration.  
3 B2 Liver Glycogenesis. The Process of converting Glucose to glycogen in the liver stimulated 
by hormone insulin. 
4 B3 Liver storage capacity. Liver glycogen holding capacity controls glycogenesis rate when it 
reaches maximum. 
5 B4 Insulin Muscle 
Glycogenesis. 
Insulin mediated glucose to glycogen conversion in the liver. 
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6 B5 Muscle storage capacity. Muscle glycogen holding capacity controls glycogenesis rate when it 
reaches maximum. 
7 B6 Insulin glucose fat 
conversion. 
Condition for glucose to fat conversion begins when insulin mediated 
glucose to glycogen conversion in the muscle reaches its maximum 
capacity.  
8 B7 Liver Glycogenolysis. Glucagon mediated glycogen to glucose conversion in the liver. 
9 B8 Insulin Adipose Tissue. Insulin stimulated glucose utilization. 
10 B10 Gluconeogenesis. Glucagon stimulated gluconeogenesis. 
11 B11 Gluconeogenesis on glucose 
to fat conversion. 
Effect of gluconeogenesis on glucose to fat conversion through muscle 
glycogen. 
12 B12 Fat energy expenditure The relation between fat as a source of fuel and fat as part of weight 
with energy expenditure.  
13 B13 Non-insulin dependent 
organ energy expenditure 
Gluconeogenesis effect on non-insulin dependent organs glucose 
utilization through energy expenditure. 
14 B14 Splanchnic organs energy 
expenditure 
Gluconeogenesis effect on Splanchnic organs glucose utilization 
through energy expenditure 
15 B15 Adipose tissue energy 
expenditure 
Gluconeogenesis effect on adipose tissue glucose utilization through 
energy expenditure 
16 B16 Muscle glycogen energy 
expenditure 1 
Gluconeogenesis effect on muscle glycogen glucose utilization 
through energy expenditure further controls glucose to fat conversion. 
17 B17 Muscle glycogen energy 
expenditure 2 
Gluconeogenesis effect on muscle glycogen glucose utilization 
through energy expenditure further controls how fast glucose to 
glycogen conversion since glycogenesis rate is dependent on the level 
of muscle glycogen. 
18 R2 Fat BMI The relation between total fat of a body and body mass index 
19 R3 BMI adipose tissue Gluconeogenesis effect on adipose tissue glucose utilization through 
BMI 
20 R4 BMI Muscle Glycogenesis Gluconeogenesis effect on muscle glycogen glucose utilization 
through BMI further controls how fast glucose to glycogen conversion 
since glycogenesis rate is dependent on the level of muscle glycogen. 
21 R5 BMI Glucose to fat 
conversion. 
Total fat effect on glucose to fat conversion through BMI effect on 
muscle glucose utilization. 
  
   III. Physical Activity level (PAL). 
Physical activity level refers how strong is our physical status from the minimum energy demand 
metabolic rate up to the maximum energy demand of human energy metabolism during our daily 
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physical activity, its unitless numerical value is the quotient of our total daily energy expenditure 
with the body basal metabolic rate (Westerterp, 2013). 
According to the joint report of FAO/WHO/UNU (Food and Agriculture Organization/World Health 
Organization/ United Nations University) Joint (2004), physical activity level varies in the society 
since physical activity differs between sedentary/Light activity, moderately active/Active and 
vigorously active lifestyles. 
    A. Light activity Lifestyle (Sedentary). 
The physical activity level in this group is between 1.4 and 1.69 because in this group they are not 
regularly doing physical exercises, mostly the daily life including daily work of this group does not 
need physical demand, for example using private car instead of using a collective transport or walk 
as a hobby, etc. 
    B. Moderately active life 
Reference to the name given, the people in this group engaged on physical demanding activities 
throughout their life.  
Physical Activity Level is between 1.7 and 1.99 because all the daily physical activities require more 
energy source, mostly the people in this group doing energy demanding exercise. 
Cycling regularly, walking regularly could be high energy demanding daily exercise. 
    C. Vigorously active lifestyle. 
The lifestyle in Vigorously active group is engaged on high energy demanding and time taking daily 
activities like swimming, walking, and running…etc. more than two hours per day. Athlete could be 
included in this group and the physical activity level is between 2 and 2.4.  
Oxygen consumption during any physical movement relies on our physical activity level (Burton et 
al., 2004) and it shifts the share of human body energy sources especially share of fats and 
carbohydrates, this carbohydrate or fat metabolization share vary according to the percentage of the 
maximum oxygen consumption Vo2 Max % (Holloszy et al., 1998). In general, increasing physical 
activity level   from mild to moderate increases usage of glucose as a source of energy (Heinonen et 
al., 2014), but increasing the duration of physical movement increases fat utilization (Jeukendrup, 
2003). 
 
  4.2.2. Endogenous factors: Blood glucose concentration through feedback relation with other 
organs or systems in the body.   
    I. Kidney 
Minerals, electrolytes, and blood glucose…etc. in human body is filtered, reabsorbed, and excreted 
through the organ kidney (Miyoshi et al., 2020).  
Sodium glucose co-transporters (SGLTs) in the Kidney reabsorbs blood glucose back to the blood 
vessels with a reabsorption rate of linearly increasing until it reaches a maximum rate as blood 
glucose concentration increases(R1) whereas the blood glucose filtration rate (average 180 liter of 
blood per day)increases linearly as blood glucose concentration increases, linearly increasing of 
glucose filtration rate decreases the blood glucose concentration which is represented by a balancing 
loop of B1(Poudel, 2013).   
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   II. Liver and muscle. 
Due to rising of blood glucose concentration above the normal range during postprandial condition, 
glucose is transported and involved on the process to be stored as glycogen highly in human organs 
of Liver(normal range is between 0-160 gram, ~80 gram) and Muscle(normal range is between 300-
700 gram ,~500 gram), the other glycogen storage sites that have a storage capacity of approximately 
100 times less than the capacity muscle glycogen are brain, heart, kidney and red  blood cells 
(Murray & Rosenbloom, 2018). 
The name glycogenosis refers to the formation of glycogen from glucose through the hormone 
insulin and glycogenosis rate refers how fast the conversion of glucose to glycogen goes in order to 
reach maximum liver glycogen capacity with a balancing loop of B2, further level of the liver 
storage controls back the conversion rate through the balancing loop of B3 because of limited storage 
capacity of the liver. 
Insulin is one of the hormones and its production relies on the amount of glucose in the blood vessel, 
the production of insulin also further determines how fast the conversion of glycogen from glucose 
in the liver and in the muscle by stimulating different hormones that are responsible during 
conversion process (Blanco & Blanco, 2017; Chadt & Al-Hasani, 2020; Vargas et al., 2020) (See 
Appendix figure 7-4).  
Liver glycogenesis rate and muscle glycogenesis rate variation due to insulin concentration in the 
blood regulate further concentration of blood glucose through the loop B2 and B4, respectively. 
Muscle glycogenesis rate is the main gate controlling the storage of glucose as glycogen in the 
muscle and the level of glycogen back determines how fast muscle glycogenesis rate through the 
balancing relation of the storage and the rate (B5). According to (Fialkowski Revilla et al., 2018), fat 
conversion from excess blood glucose after a carbohydrate diet begins when muscle glycogen 
storage is full, and further manages the level of blood glucose concentration through the loop B6.  
On the other hand, liver is the only organ that supplies back to the blood vessels from the storage of 
glucose as glycogen when blood glucose concentration is below the normal range because muscle 
has no glucose-6-phosphate to change glycogen to glucose but it involves during gluconeogenesis as 
a source of lactate even if muscle glycogen has no that much significant role during 
starvation/fasting in order to keep blood glucose concentration in the normal range (Jensen et al., 
2011). Liver supplies glucose from the storage continuously through the hormonal influence of 
glucagon on Liver glycogenolysis rate and takes blood glucose from the blood vessel continuously 
until equilibrium is reach between glycogenolysis and glycogenesis (Blanco & Blanco, 2017). 
Blood glucose concentration has an increasing and decreasing dynamics following the daily meal. 
During falling phase, the hormone glucagon secretion increases and stimulates different hormones to 
convert glycogen to glucose, the converted glucose enters to the blood vessels and raise the glucose 
concentration through the loop B7 described on figure 4-6 (Adeva-Andany et al., 2019).  
  III. Carbohydrate Utilization. 
Glucose is the fuel that is oxidized by body cell as a source of energy (Tunduguru & Thurmond, 
2017).  In the process of glycolysis, glucose enters into the cell by the glucose transporter and end up 
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to Pyruvate after several steps of reaction, pyruvate goes further to powerhouse of the cell 
mitochondria (Hall & Hall, 2020). 
Inside mitochondria, pyruvate get in to the Krebs cycle as acetyl CoA and then involved in the 
oxidation process to get energy, Co2 and H2O but when the cell is exposed to the condition where 
there is absence or shortage of oxygen in cells of skeletal muscle, lactate will be the product 
(Kumari, 2017) (see Appendix figure 7-2).  
Utilization of glucose in human body facilitated with and without the hormone insulin depends on 
which glucose transporters are the carrier to deliver the required glucose for the specific tissue cell, 
adipose and muscle tissue glucose transportation is mediated by the hormone insulin (Navale & 
Paranjape, 2016).  
o Effect of Insulin on Adipose Tissue glucose utilization. 
The collection of adipose cells in human body forms adipose tissue. Adipose tissues classified as 
white and brown adipose tissues; white adipose tissues are the main site for energy storage whereas 
the brown adipose tissues are responsible for body heat source (Bano, 2013). 
Glucose utilization in adipose tissues is regulated by insulin in the blood vessel since GLUT4 
activated by insulin has a transportation role in the delivery of glucose to the adipose tissue cell 
during catabolism. The effect of blood glucose back on it through the above physiology develops a 
balancing loop of B8 in figure 4-6.  
  IV. Gluconeogenesis. 
Gluconeogenesis is a metabolic process of getting glucose as from non-carbohydrate substrates in the 
body during shortage of glucose in human body to fulfil the energy demand for those human organs 
that are using glucose exclusively as the only source of energy like brain and eye, the main non-
carbohydrate sources that are available in human body are proteins and fats (Melkonian et al., 2020)  
(see Appendix figure 7-3). 
Lactate, glycerol, alanine, and glutamine are non-carbohydrate sources during gluconeogenesis 
(Hatting et al., 2018), the organs/tissues/cells that are involved in the process of gluconeogenesis are 
Liver, Kidney, brain, and erythrocytes (Melkonian et al., 2020). 
Based on the CLD on figure 4-6, gluconeogenesis rate activity is highly dependent on blood 
glucagon concentration but additional exogenous hormones which is not included in this paper has a 
potential to activate gluconeogenesis (growth hormone, epinephrine, and cortisol) (Dashty, 2013), 
the hormone glucagon managing gluconeogenesis rate directly when there are enough non 
carbohydrate sources are available during the conversion process (Adeva-Andany et al., 2019). 
The human physiology above classifies the effect of blood glucose on gluconeogenesis through the 
hormone glucagon in two paths, now let us see how the effect of gluconeogenesis on blood glucose 
concentration. 
▪ Direct effect on blood glucose concentration as a supplier of blood glucose.  
▪ Indirect effect on blood glucose concentration through body weight or body fat as a user 
since body weight variation has effect on energy expenditure.  
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  A. Direct effect of Gluconeogenesis on blood glucose concentration.  
Based on the physiology of gluconeogenesis, the conversion of non-carbohydrate to glucose 
increases the level of blood glucose concentration by using glucagon hormone as an initiator of 
enzyme reaction for the sake of glucose production, all those action and reaction processes connected 
through blood glucose concentration builds a balancing loop of B10 since hormone glycogen is 
inversely related to blood glucose concentration.  
  B. Indirect effect of gluconeogenesis on blood glucose concentration through body weight or body 
fat as energy user.  
According to Eckel (2018), adipose cells in adipose tissue found in visceral and subcutaneous tissues 
for the storage purpose of triglycerides. Triglycerides decomposes to glycerol and fatty acids, 
glycerol’s are the only source of fat used for synthesis of glucose in the process of gluconeogenesis 
(Melkonian et al., 2020).This implies that, gluconeogenesis from fat as glycerol has effect on body 
weight  since fat as glycerol is part of the body weight, body weight and body mass index are 
proportional. 
Body mass index (BMI) (previously the name was Quetelet index) is calculated by considering 
weight in kg and height in meter with a unit of kg/m2, it is a good indication of fat in the body 
(Nadeem et al., 2018). 
The variation of Body mass index in human body determines energy requirement for metabolism, 
visceral adiposity (VAT) and the total body weight, the relation is described as follows. 
➢ Effect of BMI on Body weight (Total fat). 
Body mass index has effect on total body weight since body weight is proportional to total body fat 
(Nadeem et al., 2018), the relation between body mass index and total body weight engaged in a 
reinforcing loop of R2(figure 4-6). 
➢ Effect of BMI on visceral adiposity. 
Fat composition in human body is mainly grouped in to two types based on the place where it founds 
anatomically, those are subcutaneous Adipose Tissue (SAT) and visceral adipose tissue (VAT).  
Reference to Shuster et al. (2012), visceral adiposity is the prevalence of excess fat in adipose tissue 
around the abdomen and inside the abdomen as ectopic fat which surrounds the organs inside 
abdominal cavity. Adipose tissue is originally from lipoblasts and visceral adiposity, abdominal 
obesity has a significant complication in human physiology than subcutaneous obesity, impaired 
glucose utilization is one of the problems when there is change on visceral adipose tissue (Lim et al., 
2020).Impaired glucose utilization effect is further entrenched on muscle and adipose tissues as 
follows. 
i. Effect of Visceral adipose tissue (intra-abdominal fat) on adipose tissue glucose utilization. 
Adipose tissue expansion during weight gain conditions shows change on the adipose cell 
size(hypertrophy) or on the number of adipose cells (hyperplasia) (Tandon et al., 2018). 
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The enlargement of adipose tissue above the cell limit develops poor sensitivity of the cell for insulin 
during burning of glucose in the cell, reduction of insulin sensitivity and expansion of the cell above 
the limit aggravate inflammation of the cell and gets more worse on glucose metabolism on adipose 
cells (Longo et al., 2019). In general reduction of glucose metabolism in the adipose cell decrease 
blood glucose drainage by adipose cells, this implies blood glucose concentration do not decrease as 
expected.  
The influence of visceral adipose tissue through adipose tissue glucose utilization on blood glucose 
concentration and the effect of blood glucose concentration on visceral adipose tissue through 
gluconeogenesis based on the physiological explanation above concludes the inter relation of all the 
organs/hormones/cells engaged in the line as a loop have a reinforcing behavior and represented in 
the diagram as R3.  
ii. Effect of Visceral adipose tissue (intra-abdominal fat) on Muscle tissue glucose utilization. 
There are three types of muscle tissues that are found in human body for generating physical power 
and supporting organ function (Dong et al., 2020), skeletal muscles are voluntary that supports 
skeletal bone whereas cardiac and smooth muscles are involuntary and additionally can give 
response for hormones (Migliozzi, 2016).  
Insulin stimulated glucose metabolism in skeletal muscle decreases as insulin sensitivity decreases 
because of visceral tissue induce sensitivity of muscular response on glucose utilization (Ferrannini 
et al., 2008). 
As muscle glucose utilization effectiveness relies on existence of the visceral adipose tissue, muscle 
glycogen storage will face a problem to reach its maximum capacity and the case further influence 
blood glucose concentration.  
              1. Directly through muscle glycogenesis rate by making a closed reinforcing loop of R4 
through hormone glucagon.  
              2. Through the fat formation from glucose since formation of fat from glucose begins to be 
processed when muscle glycogen storage is full (Fialkowski Revilla et al., 2018; Hall & Hall, 2020; 
Jensen et al., 2011). This human physiology condition influences  
Total fat in the body back and makes reinforcing loop of R5 since it increases the total fat of the 
body when there a possibility of glucose to fat conversion. 
Blood glucose concentration by developing inter relational effect on one to the other in a balancing 
loop of B11 due to the blood glucose base glucagon production on the process of gluconeogenesis, 
gluconeogenesis further influences total fat.  
➢ Effect of BMI on Energy expenditure 
Reference to the joint report of FAO/WHO/UNE Joint (2004), total energy expenditure of human 
beings can be formulated based on age and weight (BMI=Weight per height2), this report shows 
weight variation is one of the primary parameters which determines how much energy is needed for 
human beings in daily life basis.  
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Basal metabolic rate is the minimum daily energy metabolic rate to ensure vital human organs 
working properly which is calculated from the total energy expenditure, estimated basal metabolic 
rate for adult human beings at specific weight takes 35 to 70 % of the total energy expenditure 
(Kliemann et al., 2020). 
▪ Energy expenditure 
Resting metabolism which is the minimum energy demanding uses dominantly fat but share of 
glucose increases linearly for both trained and untrained human beings when energy demand 
increases because of change of physical activity (Burton et al., 2004). 
Fat in adipose tissue is source of energy during fat metabolism, share of fat in the body as a source of 
fuel is share of body weight, this implies the weight of a body directly controls the energy required 
by the body and the effect further influences the weight of the body through total fat by developing 
of balancing relation in the loop of B12.  
As far as metabolic rate of a human being is concerned, metabolism occurs in different tissue cells by 
using glucose or fat as a source of energy as follows. 
1. Brain Glucose Utilization. 
Brain and nerves system are the major organs/system that are not using insulin because glucose is 
transported to the organs by using non-insulin dependent glucose transporter (Bano, 2013). In 
addition to physical activity level, body weight is the only factor that determines how many grams of 
glucose is going to burn to get enough amount of energy to assure maximal well-functioning of brain 
and nerves system in human body (Pellerin & Magistretti, 2003). 
The body weight is varying according to the fat that human body uses as glucose during starvation in 
the process of gluconeogenesis, gluconeogenesis relies on the concentration of glucagon available in 
the blood stream (see gluconeogenesis part above).  
From the above explanation, the loop that explains in detail about the connection of glucagon 
through gluconeogenesis is represented by a closed balancing loop B13.  
2. Splanchnic Organs glucose utilization (Other’s insulin independent organs). 
Splanchnic organs are a collection of vital organs found in the cavity of abdomen, some of the organs 
in this group are intestine, liver, kidney (Tappy, 2020). 
Energy expenditure on the share of glucose for splanchnic organs have an indirect relation with the 
blood glucose concentration as follows. The body weight is varying according to the fat that human 
body uses as a glucose during starvation in the process of gluconeogenesis, gluconeogenesis relies on 
the concentration of glucagon in the blood vessel (see gluconeogenesis).  
From the above explanation, the influence of blood glucose concentration back on itself through the 
other organs/hormones/cells described by a closed balancing loop of B14, the loop is developed due 
to direct involvement of the hormone glucagon on the process of gluconeogenesis since glucagon is 
produced due to less blood glucose. Total fat of the body is part of the body weight and controlled by 
gluconeogenesis and further influences the amount of glucose used by the splanchnic organ’s cells. 
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3. Adipose Tissue glucose utilization. 
The collection of adipose cells in human body forms adipose tissue (Chait & den Hartigh, 2020). 
Adipose tissues classified as white and brown adipose tissues; white adipose tissues are the main site 
for energy storage whereas the brown adipose tissues are responsible for body heat source (Bano, 
2013). 
Energy expenditure on the share of glucose for adipose tissue has an indirect relation with the blood 
glucose concentration as follows. 
The body weight is varying according to the fat that human body uses as a glucose during starvation 
in the process of gluconeogenesis, gluconeogenesis relies on the concentration of glucagon in the 
blood stream (see gluconeogenesis).  
From the above explanation, the influence of blood glucose concentration back on itself through the 
other organs/hormones/cells described by a closed balancing loop of B15, the loop is developed due 
to direct involvement of the hormone glucagon on the process of gluconeogenesis since glucagon 
secretion is relied on the level of blood glucose. Total fat of the body is part of the body weight and 
controlled by gluconeogenesis and further influences the amount of glucose used by the adipose 
tissue cells.  
4. Muscle tissue glucose utilization. 
Human body physical movement is supported by musculoskeletal systems, muscle and skeleton align 
together by tendons (Dave et al., 2020). 
Glucose metabolism in skeletal muscle takes the highest share of total glucose next to brain (Bano, 
2013), the amount of muscle glucose utilization indirectly influences the blood glucose concentration 
through.  
a. Muscle glycogenesis. 
When glucose utilization varies, muscle glycogenesis also follows the dynamics of the utilization to 
fill up the gap in muscle glycogen due to oxidized glucose on the muscle. Rate of muscle 
glycogenesis directly controls the blood glucose concentration; the effect further determines the 
existence of gluconeogenesis through the hormone glucagon. The closed loop that is generated due 
to the physiological relationship of the organs/hormones/cells is well described by a balancing loop 
of B17.  
b. Glucose to Fat conversion. 
Formation of fat from excess blood glucose is dependent on the amount of glycogen stored in the 
muscle, the conversion begins when the muscle glycogen storage holds its maximum capacity 
(Fialkowski Revilla et al., 2018). The physiology that described above develops a closed balancing 
loop of B16.  
  4.2.3. Endogenous hormones in the process of blood glucose Homeostasis. 
Blood glucose homeostasis largely regulated by the hormones produced in the body, insulin and 
glucagon are the most dominant hormones that produced from the alpha and beta cells of the organ 
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pancreas to facilitate glucose metabolism and working to elevate blood glucose concentration 
respectively, the amount of the hormones produced in the pancreas relies on the concentration of 
glucose in the blood vessel.  
  4.3.1.   Insulin. 
Insulin is an endocrine hormone of 51-amino acid secreted from pancreas of beta cells in islet of 
Langerhans (Ojha et al., 2019).  Insulin production in human body is stimulated by the presence of 
non-nutrients(hormones) and nutrients (Wilcox, 2005).  
Insulin production in beta cells of the pancreas allows glucose into the cell by the help of glucose 
transporters (GLUT) and going through different reactions by the main mediator of enzymes in the 
cell until the release of insulin (Yaribeygi et al., 2019)(see Appendix Figure 7-4).  
Secreted insulin from the pancreas of beta cells regulates blood glucose concentration during 
metabolism  on insulin sensitive tissues of muscle, adipose tissue and liver (Petersen & Shulman, 
2018), fatty acids and glycerol release as a product of triglycerides disintegration suppressed by 
insulin (Czech, 2020).  
Normal physiology of glucose uptake in muscle and adipose tissue cells are regulated by insulin 
since production of glucose transporters (GLUT4) inside the cell that allows glucose to get into the 
cell is dependent on insulin through insulin receptor located at the cell membrane of the cell (Leto & 
Saltiel, 2012). 
Glucose is water soluble nutrient which can float over the outer part of a cell instead of getting into 
or diffuse in the cell because the outer part of a cell (cell membrane) with a thickness of 7-9 nm is 
made up of phospholipids (Navale & Paranjape, 2016; Wallig et al., 2017). 
The interaction of insulin receptor and insulin develops further molecular reactions inside the cell, 
after some steps of molecular interaction inside the cell Glucose transporter (GLUT 4) activated and 
make a tunnel on the cell membrane to let glucose in to the cytoplasm of the cell (Hoeg-Jensen, 
2021) (See appendix figure 7-5). 
  4.3.2.   Glucagon. 
Glucagon is a hormone of 29-amino acid peptide and secreted from the alpha cell in islet of 
Langerhans of the organ pancreas due to the condition of low blood glucose concentration happens 
in the blood vessels (Rix et al., 2015). 
Hepatic glucose production during hypoglycemia is stimulated by glucagon (Galsgaard et al., 2019), 








Chapter 5 .  Model Analysis 
5.1. Insulin Resistance. 
5.1.1. Model Setting  
The model needs to set different variables by taking the health status of the person with insulin 
resistance and with normal health condition under consideration since the model considers all adults 
with and without a sign of morning high blood glucose level but in this part the author considers the 
volunteers with a high blood glucose level in case of insulin resistance (Henry et al., 1986). 




The model starts to simulate at 7 Since the first sample took at 7 A.M from those 
volunteers with a problem of Insulin resistance. 
Stop time  
the model ends at 10 since the last sample took from the reference was at 10 A.M 
Initial Blood glucose in 
gram  
 Blood concentration in the model initialize with 14.9 mmol/l (13.5 gram) since 
morning blood concentration was 14.9mmol/l. 
Average Body weight  
103 kg 
Average height  
1.74 m 
Energy Expenditure 
during the test 
Energy expenditure is set (PAL=1.4) by considering the volunteers are admitted just 
to take the samples 
Physical Activity level 
Physical activity level is set at the basal level (PAL=1.4) since participants are at rest 










Stella architecture 2.1 version software.  
Food intake for Blood 
glucose Con. test 
75gm since participants took 75mg during blood glucose concentration test. 
 
5.1.2. Simulated Behavior Analysis. 
Blood glucose concentration normally expected to increase and decrease when there a difference 
between daily carbohydrate intake and glucose utilization, the simulated results on figure 5-1 
indicates blood glucose concentration of insulin resistance voluntaries have increasing and 





Figure 5-1. Simulated Blood glucose concentration result for insulin resistance patients before treatment. 
Reference to the figure 5-1, blood glucose concentration level fall linearly for 6 minutes (0.1 hour) 
by following a gradual raise until it reaches its maximum point within 36 minutes (0.6 hour), and 
then it goes down slowly for a longer period relative to the time has taken to reach the maximum 
level. The unequal increasing or decreasing rate of blood glucose concentration during the specified 
period needs further time-based analysis to see how the physiology of organs and its contribution 
regarding blood glucose concentration clarified as follows. 
At 7 A.M. 
The simulated result of blood glucose concentration initialized with 14.9 mmol/l (13.5 gram) since 
the sample of blood glucose concentration took from the volunteers participated in the research. 
From 7A.M to 7:06 A.M(7.1). 
Linearly decreasing of Blood glucose concentration from 14.9 mmol/l to 13.7 mmol/l indicates that 
there is a higher drainage of blood glucose relative to glucose entering to the blood vessel, organs or 
cells in the body using blood glucose from capillaries of the blood vessel as a source of energy and 




Figure 5-2. Simulated graph of the role of kidney on glucose filtration and reabsorption. 
i. Kidney in the process of glucose Filtration 
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Blood glucose going through the process of filtration decreases linearly even the effect decreases the 
blood glucose concentration through the balancing loop of B1 but the capacity of kidney to reabsorb 
the glucose under filtration reaches its maximum level and adds more glucose to the blood vessel 
through the reinforcing loop of R1 since glucose reabsorption rate is constant.  
Based on the physiology and the analysis above, the rate difference between kidney glucose filtration 
and reabsorption, kidney forced to excrete excess glucose with urine(glucosuria) with a removal rate 
of the name given Glucose removal rate through urine (see Figure 5-2).  
Consequently, the leading role of kidney in this specific time is removing excess glucose because the 
filtration rate through the balancing loop B1 is dominating over the reinforcing loop (R1) of 
reabsorption rate. 
ii.        Muscle, Liver and Adipose tissue as a storage. 
Continuous conversion of glucose to glycogen (glycogenesis) in the liver and muscle takes insulin as 
a stimulator, the amount of glucose in the blood vessel and liver storage/muscle storage level into 
consideration but in case of the reverse process(glycogenolysis) in liver hormone glucagon 
stimulates the process instead of insulin. 
 
 
Figure 5-3. Simulated results for liver, muscle, and adipose tissue glucose conversion rate through the process 
of glycogenesis, glycogenolysis and glucose to fat conversion, respectively. 
Reference to the simulated result in Figure 5-3, contribution of liver on the process of converting 
glucose to glycogen (glycogenesis) is zero because liver storage has no free space to store more 
glucose, so the closed balancing loop(B3) dominates the effect of insulin on liver glycogenesis 
through the loop(B2). Liver as a glucose supplier due to liver glycogenolysis is zero since glucagon 
hormone production is less in the body to convert glycogen to glucose. 
Muscle glycogenesis rate is small because the muscle needs to have enough amount of insulin (B4) 
to overcome the effect of excess fat on the muscle glycogenesis through the loop R5, then the effect 
further limits the conversion of glucose to fat in adipose tissue. 
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Therefore, the role of liver as a user in the process of glycogenesis and as a supplier in the process of 
glycogenolysis has no contribution but muscle has a little contribution as a user of blood glucose to 
compensate the muscle glycogen used by the body for 6 minutes. 
iii.         Glucose utilization in the organs or cells. 
Total body weight base energy requirement for the organs takes glucose into consideration as a 
source, simulated results of glucose oxidation in Figure 5-4 shows in detail.  
Glucose oxidation in the body is expected to be constant since the volunteers participated in this 
research has constant physical activity level during blood glucose assessment.  
Based on the simulated result in Figure 5-4, Brain burns highest amount of glucose because glucose 
is the only source of energy for brain in normal condition and splanchnic organs are the second one 
that uses glucose as an energy source. 
 
 
Figure 5-4. Simulated results of glucose oxidation rate in the body. 
 
iv.        Blood glucose suppliers. 
Assimilation of glucose as daily intake through GIT and gluconeogenesis through the organ liver and 
kidney from non-carbohydrate sources are the only supplier of glucose to the blood vessel.  
Based on the simulation result on Figure 5-5, gluconeogenesis rate is zero since there is no enough 
glucagon production in the body to convert non carbohydrate nutrients into glucose but carbohydrate 
intake through GIT increases linearly from 0 to 34.9 gram per hour. As a glucose provider, glucose 
from GIT is dominant over gluconeogenesis to provide glucose for blood vessel.  
Conclusion: Blood glucose concentration linearly decreases for the first 6 minutes due to the 
dominant effect of Brain using glucose as a source of energy through the balancing loop of B13 over 





Figure 5-5. Simulated result of glucose providers to blood vessel. 
 
From 7:06(7.1) A.M to 7:48 A.M(7.8). 
Blood glucose concentration increases decreasingly from initial level of 13.7 mmol/l to its highest 
concentration of 22.3 mmol/l for 42 minutes stay since the hourly carbohydrate intake is greater than 
the total amount of glucose drained by different organs/tissues/cells out from the blood vessel 
according to the anatomy and physiology of the body, glucose providers/users to/from the blood 
vessel can be classified as follows. 
i. Kidney for filtration. 
Kidney filtration rate increases decreasingly, and the reabsorption rate reaches its maximum capacity 
and becomes constant, rate difference between kidney glucose filtration and reabsorption determines 
the amount of glucose excreted as excess through urination, excretion rate increases decreasingly by 
following the filtration rate since reabsorption is constant (See Figure 5-2). 
In this period glucose removed from the whole body through urine (Glucosuria), the existence of 
glucose in the urine can be considered as one of sign of increasing blood glucose concentration.  
Therefore, the net role of kidney in this specific period is excretion of glucose from the whole body 
together with urine since the loop developed due to filtration rate B1 is dominant over the closed 
loop developed due to reabsorption rate R1. 
ii. Muscle, Liver and Adipose tissue as a storage. 
During the process of Glycogenesis in the muscle and in the liver, glucose transported from the 
blood vessel to be stored as glycogen but in the process of glycogenolysis in liver, glucose delivered 
back to the blood vessel from glycogen storage in the liver. 
Reference to the simulated result in Figure 5-3, liver contribution on draining glucose from blood 
vessel (glycogenesis) or as a glucose supplier due to glycogenolysis is almost negligible since liver 
glycogenolysis become active when blood glucose concentration is lower than the normal range and 
glucagon is enough in the blood. Muscle glycogenesis begins to increase increasingly by following 
increase decreasingly until it reaches its maximum level since the effect of insulin on muscle 
glycogenesis become stronger through the balancing loop of B4. Comparative limitation of muscle 
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glycogenesis rate with muscle glycogen burning rate, allows to have more free storage place in the 
muscle and then further hinders the conversion of glucose to fat.  
Therefore, the role of liver as a glucose storage does not use glucose from the blood vessels or does 
not supply glucose from the storage but muscle shows improvement on the conversion of glucose to 
glycogen whereas conversion of glucose to fat is zero. 
iii. Glucose utilization in the organs or cells. 
Total body weight base energy requirement for the organs uses glucose and fat as a source, simulated 
results of glucose oxidation in figure 5-4 shows in detail.  
Glucose oxidation in the body is expected to be constant since the volunteers participated in this 
research has constant physical activity level during blood glucose assessment.  
Based on the simulated result on figure 5-4, Brain burns highest amount of glucose because glucose 
is the only source of energy in normal condition and splanchnic organs are the second one that uses 
glucose as an energy source.  
Muscle and adipose tissues use less amount of glucose during this period, the glucose utilization on 
adipose tissue begins to increase slowly because adipose tissue needs insulin to oxidize glucose (B8), 
and with the same physiology the effect of insulin on muscle is described on muscle glycogenesis. 
Therefore, glucose oxidation in the brain cell keeps being dominant over the other tissues, but 
adipose tissue due to increasing of insulin in the blood shows an improvement to nourish adipose 
tissues cell.  
iv. Blood glucose suppliers. 
Assimilation of glucose as daily intake through GIT and gluconeogenesis through the organ liver and 
kidney from non-carbohydrate sources are the only supplier of glucose to the blood vessel.  
Based on the simulation result on figure 5-5, gluconeogenesis rate is remaining zero since there is no 
enough glucagon production in the body to convert non carbohydrate nutrients into glucose but 
glucose intake through the GIT as a dominant supplier provides glucose to the blood vessel even if 
glucose intake decreases decreasingly.  
From 7:36(7.8) A.M to 10:00 A.M. 
 Blood glucose concentration decreases decreasingly from its uppermost value of 22.3 mmol/l to 14.9 
mmol/l until 10 o’clock. The blood glucose dynamics shows that the organs or cells that are using 
blood glucose as energy source oxidizes more glucose than the organs supplying glucose to the blood 
vessel. providing to or using blood glucose from blood vessels varies according to the organs glucose 
requirement and organs capacity to glucose oxidation, based on the simulated results the author 
shows in detail as follows, 
i. Kidney in the process of glucose filtration. 
 Reference to the simulated result in Figure 5-2, the removal of glucose through urinary tract with 
urine decreases decreasingly by following the filtration rate pattern of the kidney because kidney still 
have a capacity limitation on the reabsorption process even less glucose is removed from the body 
relative to the increasing phase. 
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Therefore, the net role of kidney in this period is excretion of glucose from the whole body through 
urinary tract with urine since the loop developed due kidney filtration rate B1 is dominant over the 
closed loop through reabsorption rate R1 but the dominancy difference getting closer relative to the 
previous period described in between 7:06 and 7:48 o’clock. 
ii. Muscle, Liver and Adipose tissue as a storage. 
Using glycogen from the storage as a source of energy allows glycogen synthesis from glucose 
through B5 in the process of muscle glycogenesis, synthesis of glycogen needs insulin through the 
balancing loop of B4. Based on the simulated result on Figure 5-3, muscle glycogenesis rate 
decreases to fill up glycogen in the muscle by following availability of insulin through B4 because 
when accessibility of insulin in the blood decreases muscle glycogenesis decreases even if there is 
available place in the muscle to store glycogen (figure 5-6 and figure 5-7), the presence of free 
storage place in the muscle prevents glucose to fat conversion. 
Glycogenesis in the liver has no contribution for this specific period (see figure 5-3). 
 
 
Figure 5-6. Remaining free place for glycogen storage in muscle. 
 
 




iii. Glucose utilization in the organs or cells. 
Reference to the simulated result in figure 5-4, brain burns highest amount of glucose because 
glucose is the only source of energy in normal condition and splanchnic organs are the second one 
that uses glucose as an energy source.  
Muscle and adipose tissues use less amount of glucose during this period, glucose utilization on 
adipose tissue decreases due to decreasing of insulin in adipose tissue to oxidize glucose (B8), and 
with the same physiology the effect of insulin on muscle is described on muscle glycogenesis. 
Therefore, glucose oxidation in the brain cell keeps being dominant over the other tissues, but 
adipose tissue due to dependence on insulin decreases blood glucose oxidation rate.  
iv.  Blood glucose suppliers. 
As a provider of Glucose through GIT and through gluconeogenesis, gluconeogenesis has no 
contribution on the blood glucose concentration but daily glucose intake through carbohydrate 
assimilation in the intestine has a dominant role over gluconeogenesis even it is decreasing gradually 
(see figure 5-5). 
Summary of required blood glucose as energy source and oxidized blood glucose by the organ cells. 
The simulated and calculated results in figure 5-8 and Table 5-2 shows that splanchnic organs 
glucose usage as a source of fuel is the second one next to brain glucose oxidation , both organs cells 
have got enough energy from glucose since required glucose is equal to the oxidized glucose (100%) 
but in case of muscle and adipose tissue, still there is a higher requirement of glucose as energy 
relative to the glucose oxidized in the muscle and adipose tissue cell even if there is an improvement 
on adipose tissue glucose oxidation between 7.8 to 8.8 hour.  
Table 5-2. Comparison table for oxidized and required glucose in Organ cell. 











by the cell 
Brain 
7-7.1 3.63 3.63 100 
7.1-7.8 3.63 3.63 100 
7.8-10 3.63 3.63 100 
Splanchnic Organs 
7-7.1 1.62 1.62 100 
7.1-7.8 1.62 1.62 100 
7.8-10 1.62 1.62 100 
Adipose tissue 
7-7.1 0.196 0.00466 2.37755102 
7.1-7.8 0.196 0.0938 47.8571429 
7.8-10 0.196 0.0485 24.744898 
Muscle Tissue 
7-7.1 1.16 0.548 47.2413793 
7.1-7.8 1.16 0.548 47.2413793 




In Muscle tissue, 47% of glucose as energy required by the cell oxidized but the rest 53% glucose 
oxidation is trapped by intra-abdominal fat (IAF) through the reinforcing loop R3 and further the 
conversion of glucose to fat is not activated since muscle glycogenesis due to B4 and B5 dominates 
over B6. 
In adipose tissue, there is glucose oxidation improvement from 2% to 47% because of the increment 
of insulin through the loop B8 but still there is a dominant effect from intra-abdominal fat (IAF) 




Figure 5-8. Simulated result of required energy by the organ cell and the oxidized glucose on the organ cell. 
 
Glucose utilization percentage indicates that the cell in the adipose tissue has no full access to 
oxidize glucose, the highly controlling effect of Intra-abdominal fat through the reinforcing loop R3 
together with the effect of less insulin production through B8 leads glucose utilization on adipose 
tissue to be less.  
Muscle tissue too has the same glucose utilization deficiency even if the percentage of glucose 
utilization is more than the Adipose tissue since muscle can burn the stored glycogen without using 
insulin, Muscle glucose utilization is less than the required amount of glucose in the cell by ~ 53 % 
since the effect of intra-abdominal fat (IAF) through the reinforcing loop of R5 deters muscle 





5.2. Insulin Production variation role on glucose metabolism. 
As an objective of the thesis, the author wants to study the effect of insulin on glucose metabolism 
since production level of insulin in the body helps to differentiate the type of diabetic’s mellitus.  
  




The model starts to simulate at 7. 
Stop time  
The model ends at 12. 
Initial Blood glucose in 
gram  
Blood concentration in the model initialize with 14.9 mmol/l (13.5 gram) since 
morning blood concentration was 14.9 mmol/l. 
Average Body weight  
70 kg since normal BMI is less than 25, now let us take BMI =23 
Average height  
1.74 m 
Energy Expenditure 
during the test 
Energy expenditure is set (PAL=1.4) by considering the volunteers are admitted just 
to take the samples 
Physical Activity level 
Physical Activity level: physical activity level is set at the basal level (PAL=1.4) 










Stella architecture 2.1 version software.  
Food intake for Blood 
glucose Con. test 
75gm since 75 gram is for testing purpose. 
Insulin Production test 
Varies from 0 to 1 to specify insulin production from 0% to 100 % respectively. 
 
According to figure 5-9, the simulated result on figure 5-10 and 5-11, adipose tissue glucose 
utilization rate and muscle glycogenesis are highly relying on the hormone insulin production. 
Adipose tissue and muscle tissue reaches its maximum after 1 hour because of the initial insulin in 




Figure 5-9. CLD Relation between hormones and blood glucose concentration. 
 
Adipose tissue utilizes glucose at maximum rate of 0.141 gram per hour for normal production of 
insulin but for those who has no insulin production, adipose tissue uses the initial insulin and 
becomes 0.0025 gram per hour, this implies that glucose utilization decreases to 0.00201/0.141=1.4 
%. therefore, almost all the cells have no enough energy during metabolism. 





Figure 5-10. Simulated result for adipose tissue glucose utilization rate and muscle glycogenesis rate. 
 
Insulin production gets maximum when pancreas works well but when the production rate decreases, 




Figure 5-11. Simulated result for insulin in the blood and blood glucose concentration. 
 
Blood glucose concentration with 100 % production is less than the rest of the insulin production 
scenarios between 8 -10 hour because insulin production was enough to burn glucose in the adipose 
and in muscle tissues but for the other scenarios blood glucose concentration keep higher due to less 
insulin in the blood to stimulate glucose utilization. 
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@ 8.8 hr. 
(%) 
Remark 
100  100 100 100 Has taken as a reference since it is normal 
production. 
50 28.8 20.3 105.5 Both in Adipose and muscle tissue rate 
decreases, but in case of blood glucose 
concentration, blood glucose become 
overloaded.  
25 7.1 5.06 106.6 
0 1.4 1 107.1 
 
5.3. Model Validation Testing. 
 
Based on the validation guidelines developed by (Barlas, 1994; Senge & Forrester, 1980; Sterman, 
2000), there are different types of testing with different procedures based on the purpose of the test. 
In the following section, those tests are described and conducted in an iterative manner to build and 
increase confidence in the model. 
5.3.1. Model Boundary test. 
Building a model boundary chart for the purpose of model boundary test is useful to summarize the 
boundary of the model by differentiating and listing the variables that already comprised in the 
model and the variables that are not included, such kind of illustration further helps to easily modify 
the model when model improvement is in need.  
 
Table 5-5. Model boundary description table. 
Model Boundary 
Endogenous Variables Exogenous Variables Excluded Variables 
  
  
 See CLD on figure 4-6. 
  
  
 See CLD on figure 4-6. 
Effect of Protein on Insulin Production 
Effect of Fat on Insulin Production 










5.3.2 Integration Error. 
Table 5-6. Integration error description table. 
 DT=0.1 DT=0.05 Comment 




Based on the simulated result all scenarios show the same but there is 
12.7 % maximum difference at 7.1 between RK2 at DT=0.1 and Euler 
at DT=0.1(Euler at DT=0.1= Cycle time at DT=0.1)  
 
See figure 5-12. 













Based on the scenario-based blood glucose concentration simulation result in fig 5-12, there is no 
that much big difference for all scenarios except at the beginning for 6 minutes (0.1hour). 
 
Figure 5-12. Simulated result of blood glucose concentration during Integration Error. 
 
5.3.3. Structure assessment. 
Structure assessment test requires consistency of the model respond to the real conditions by 
considering the purpose of the model. In this model testing stage blood glucose concentration should 
be always greater than or equal zero when there is no carbohydrate ingestion, this implies the model 
does not violate the physical low. 
Based on the simulated result of figure 5-14, blood glucose concentration is greater than 0 when 
glucose intake =0 
5.3.4. Dimensional Consistency. 
Dimensional consistency of the model tests the consistency of variables equation and its units 
without any additional unit modifications in the equation, equations with units should be meaningful. 
In this model, stella architecture automatically check the validity of the equations and its units, and 
the model runs without any error. 
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5.3.5. Extreme condition Test. 
Extreme condition test is useful to see how the model responds when exposed to different combined 
input conditions, testing the model ability is by considering the variable maximum and minimum 
extreme points based on the concept of (high. high, high. low, low. high and low. low). 
Additional Setting.  
Table 5-7. Scenario setting and result table for Extreme condition test. 
 Simulation run for 1 day (7-31). 
H =High and L=Low. 
PAL High =1.69 and PAL Low =1.4 since the model considers only sedentary life. 
Glucose intake Low =0 gram and H=500. 
Weight High =120 Kg and Weight Low =40 kg. 
 PAL Glucose Intake Weight Result 
Scenario 1 H H H  The simulated result shows blood glucose 
concentration increases during high glucose 
intake but varies according to weight and 
physical activity level whereas for low 
glucose intake gluconeogenesis keep the 
blood glucose from falling to zero. 
 
See simulated result down on figure 5-13.  
Scenario 2 H H L 
Scenario 3 H L H 
Scenario 4 H L L 
Scenario 5 L H H 
Scenario 6 L H L 
Scenario 7 L L H 
Scenario 8 L L L 
 
 
Figure 5-13. Simulated result Blood glucose concentration during extreme test. 
 
From scenario base simulation result of blood glucose concentration, the model works well in all 
scenarios as expected. 
5.3.6.   Sensitivity Analysis. 




Table 5-8. Setting and result table for sensitivity analysis. 
 Simulation run for 1 day (7-31). 
H =High and L=Low. 
PAL High =1.69 and PAL Low =1.4 since the model considers only sedentary life. 
Glucose intake Low =0 gram and H=500. 
Weight High =120 Kg and Weight Low =40 kg. 
Parameter Result and conclusion. 
PAL Based on the simulation result on Figure 5-14, 5-15 and 5-16, Blood Glucose 




Figure 5-14. Simulated sensitivity result of blood glucose concentration based on glucose intake.   
 
 





Figure 5-16. Simulated sensitivity result of blood glucose concentration based on Body weight.  
5.3.7. Family Member. 
Based on Sterman (2000), procedure to perform family member test, sample took from the 
volunteers considered as a reference as follows. 
The model needs to set different variables by taking the health status of the volunteers under 
consideration since the model considers all normal participants without any health problem and taken 
as a reference for normal blood glucose level (Freckmann et al., 2007). 
 




The model starts to simulate at 7 Since the first sample took at 7 A.M from normal 
volunteers. 
Stop time  
The model ends at 31(one day duration).  
Initial Blood glucose in 
gram  
 Blood concentration in the model initialize with 4.29 mmol/l (3.9 gram) since 
morning blood concentration was 4.29 mmol/l. 
Average Body weight  
70 kg (calculated from the given BMI of 23kg/m2). 
Average height  
1.74 m (not given, assumed based on the given BMI). 
Energy Expenditure 
during the test 
Energy expenditure is set (PAL=1.4) by considering the volunteers are admitted just 
to take the samples 
Physical Activity level 
Physical activity level is set at the basal level (PAL=1.4) since participants are at rest 










Stella architecture 2.1 version software.  
24 hours Food intake 







Figure 5-17. Reference mode of a normal blood glucose concentration adapted from (Freckmann et al., 2007). 
 
 
Figure 5-18. Simulated result of normal human volunteer’s blood glucose concentration. 
Figure 5-17 and figure 5-18 shows similarities on the behavior but there is a magnitude difference, 
this implies the model also works for other groups in addition to insulin resistance patients. 
5.3.8.   Behavior Anomaly Test. 
Behavior anomaly test is useful to know how the selected loop or variable is important for the model. 
By doing analysis on the knockout loop and its effect on the behavior of the main stock, it becomes 
easy to conclude how the importance of the specific loop on the model. 
For example, it is clear to see the effect of insulin on the blood glucose concentration and other 
tissues by knock out the insulin loop (see figure 5-10 and 5-11), knock out insulin loop means 
consider insulin production is zero. 
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5.3.9.   Behavior Reproduction Test. 
Behavior reproduction test is one of the methods that shows the ability of the model in replicating the 
real reference mode by measuring, calculating the simulated and the main reference data. The degree 
of accuracy indicates how the whole model is working well, this approach can be calculated by using 
Mean absolute Error (MAE), Mean absolute percent error (MAPE) and Root Mean square error 
(RMSE). 
 
Table 5-10. Blood glucose concentration behavior reproduction test. 








Mean absolute percent 
error (MAPE) % 
Root Mean square 
error (RMSE) 









7.5 18.1518152 21.3 
8 20.6270627 21.9 
9 20.0770077 17.5 
10 17.3267327 14.9 
Behavior reproduction test indicates that the dynamics of both the reference and the simulated data 
have the same pattern, and both are in phase, table 5-10 above shows in detail to decide how much 
the model is representing adult blood glucose homeostasis. 




Figure 5-19. Blood glucose concentration for both reference mode and simulated result. 
 
5.3.10. Summary of Model test. 
Generally, reference to the guidelines and procedures of testing a model by (Sterman, 2000), 




Table 5-11. Summary of results for the specific type of test. 
Type of Test Result Remark 
Boundary Test valid Based on boundary test guideline, some of the parameters listed 
excluded as exogenous; parameters will be under consideration 
during upgrading the model (future work).   
Structure assessment   valid Published sources are the foundation of the structure; structure 
improvement during model upgrading on future work. 
Dimensional Consistency  valid Equations and units in the model are consistent. 
Behavior Anomaly Test  valid Specific loop importance detected: importance of insulin as an 
example is detected by the behavior anomaly test. 
Extreme Condition test   valid Model is working well during extreme test  
Integration Error Test  valid All types of integration methods are almost the same. 
Behavior Reproduction  valid There is quantitative difference but have the same pattern. 
Sensitivity Analysis  valid Blood glucose concentration shows sensitivity for some of the 
parameters, glucose daily intake could be example. 
Family member  valid Additionally, Model can generate well for other conditions but there 


















Chapter 6 .  Policy and Policy implementation. 
 
6.1. Proposed Policy. 
The coherence of a system dynamic approach helps us to easily investigate the main cause of the 
problem by following a detailed analysis, based on the analysis at the behavior of blood glucose 
concentration for participants who is considered as a reference mode of the problem with insulin 
resistance in the previous chapter, the author designs efficient policy as a treatment of insulin 
resistance by using modeling software which is applicable in system dynamic approach to get rid of 
the main cause of the problem before aggravating the diseases. 
The author focuses to lower the morning blood glucose concentration level less than 7 mmol/l(Tang 
et al., 2019) as a treatment of insulin resistance by making a policy of considering the main cause 
of elevated morning blood glucose level since elevation of morning blood glucose level greater than 
7 mmol/l has long run complications on cardiovascular, kidney, pancreas, eye…etc. if not treated 
early, and also rising of morning  blood glucose level indicates shortage of glucose utilization on 
muscle and adipose tissues, shortage of glucose utilization also has a complication by following 
inflammation on the tissues. 
The aim of the policy is to achieve the goal through direct and indirect controlling mechanisms, 
setting a goal and controlling body fat is the first direct fat controlling way of the human physiology 
and then body weight controlling mechanism indirectly controls blood glucose concentration. 
The policy application throughout the policy time horizon described in detail as follows.  
  
1. Proposing an improvement on adipose and muscle tissue glucose utilization through 
body fat reduction by setting body fat goal, proposed body fat goal has a minimum effect 
on glucose utilization in those specific tissues because fat in adipose and muscle 
tissues limits glucose utilization.  
Fat reduction is applied on excess fat beyond body fat goal by controlling fat and glucose 
daily intake since excess glucose has a possibility to be converted to fat. 
  
2. By following body fat reduction, proposing daily net glucose in the body to be zero by 
using daily carbohydrate intake based on the total daily energy expenditure (Daily 
carbohydrate intake = total daily glucose oxidation), balancing daily intake and usage of 
glucose in the body become useful for human body due to the following benefits.  
• To have enough glucose in the blood vessel and prevents the blood glucose 
concentration level above the normal range since blood glucose concentration 
above the normal has long run complications on the vital organs and tissues.  
•  It prevents conversion of excess glucose to fat.  





Figure 6-1. Proposed policy structure. 
 
In the figure 6-1 above, policy starts at 7 o'clock after initializing blood glucose concentration from 
the volunteers participated in and ends after 2167 hours (about 3 months) since blood glucose 
concentration has taken from the participants when they were average weight of 103 Kg, 2167 
hours means 3 months at the last day of treatment at 7 o'clock in the morning (7 o'clock considered 
as a morning blood glucose concentration after the policy). During this treatment period (see 
treatment phase on 6.3.1) the difference between the desired and the actual fat in the body 
decreases gradually, but policy adjustment period determines how fast the current fat reaches the 
desired body fat weight. 
 
6.2. Policy Hypothesis. 
During the treatment period of 3 months, fat weight in the body reaches to its desired goal through 
the process of oxidation of fats but compensation of fat by using a daily intake of fat through the 
balancing loop of B18 keep on filling up the gap between the desired and the current fat weight in 
the body (see figure 6-2).  
Oxidation of fat in the figure 6-2 shows that controlled by body weight through energy expenditure 
(B12 in figure 6-3), the variation of weight due to the goal indirectly influences the current weight of 
the body by taking compensation of fat as daily fat intake and oxidation of fat into consideration 






Figure 6-2. Policy closed loop diagram. 
 
A gradual decreasing of body weight decreases a daily intake of carbohydrate through the reinforcing 
loop of R6 since carbohydrate daily intake is calculated based on the participants daily energy 
expenditure of the body. 
 
 




6.3. Policy Analysis. 
Investigating the proposed policy in detail shows how the body responds to the proposed policy in 
order to reach the goal as a treatment of insulin resistance, this policy can be grouped and analyzed 
in to two sub phases, the first phase is the treatment phase and testing is the second phase.  
6.3.1. Treatment Phase. 
Treatment phase runs for 2160 hours from 7 o’clock to 3rd month morning 7 o’clock (2167) by taking 
the participants real average data as an input for the simulation result. 
Model Setting: 
Table 6-1. Model setting during treatment phase. 
Variable Description 
Start time 
The model starts to simulate at 7 Since the first sample took at 7 A.M from 
those volunteers with a problem of Insulin resistance. 
Stop time  
The model ends at 2167 hour.  
Initial Blood glucose in 
gram  
First day morning 7 o’clock Blood glucose in gram =13.5 g Since blood 
glucose concentration =14.9 mmol/l =270mg/dl=13.5 g. 
Average Body weight  
103 kg 
Average height  
1.74 m 
Total fat goal  
BMI goal =25 kg/m2 => Total fat goal = 30.4 Kg 
Physical Activity level 










Stella architecture 2.1 version software  
Policy energy 
expenditure 
Policy energy expenditure during the treatment phase is based on a daily 
scheduled activity for sedentary lifestyle (see table 6-2) 
 
Table 6-2. Hourly activity of sedentary life adapted from Joint FAO/WHO/UNU report(Joint, 2004). 
Sedentary or light activity lifestyle 







Sleeping 1 8 
8 
Personal care (dressing, showering 2.3 2.3 
1 
Eating 1.5 1.5 
1 
Cooking 2.1 2.1 
1 
Sitting (Office work, selling, produce, tending shop) 1.5 12 
8 




Driving car to/from work 2 2 
1 
Walking at varying paces without a load 3.2 3.2 
1 






There are two main types of treatment policy, those two main policies are designed based on how 
many grams of carbohydrate eat per day with and without using non carbohydrate (fat and protein) 
sources from our body.  
6.3.1.1 Policy A. 
Only daily carbohydrate intake is a source for blood glucose. 
In this policy type, blood glucose is supplied by daily carbohydrate intake, daily carbohydrate intake 
could be calculated based on total energy expenditure as follows. 
Daily carbohydrate intake= (Carbohydrate intake calibration coefficient) * (Total daily energy 
expenditure)  
where, Carbohydrate intake calibration coefficient shows how much (percentage or it can be between 
0 and 1) is the daily carbohydrate intake relative to total daily energy expenditure. 
Let Carbohydrate intake calibration coefficient as CICC. 










Figure 6-5. Simulated result of fat converted to glucose and glucose from non-carbohydrate nutrients from the 
body under policy A and CICC =1 
  
Figure 6-6. Simulated result of BMI and Body weight under policy A and CICC =1. 










Figure 6-8. Simulated result of fat converted to glucose and glucose from non-carbohydrate nutrients from the 
body under policy A and CICC =0.94. 
  
Figure 6-9. Simulated result of BMI and Body weight under policy A and CICC =0.94. 
6.3.1.2 Policy B. 
Both daily carbohydrate intake and body fat are a source for blood glucose. 
In this policy type, blood glucose is supplied by daily carbohydrate intake and fat from the body 
through the process of gluconeogenesis (see B10 on CLD). Dual use of body fat as a source of 
glucose through the process of gluconeogenesis and fat as a source of energy for fat utilization (see 
B10 and B12 Figure 6-3) become more effective in this type of treatment.  
i) At ACCI=0.93, implies Daily carbohydrate intake = 93 % of total daily energy 
expenditure and the rest blood glucose for glucose utilization is covered by the 






Figure 6-10. Simulated result of blood glucose concentration under policy A and CICC =0.93. 
 
  
Figure 6-11. Simulated result of fat converted to glucose and glucose from non-carbohydrate nutrients from 








ii) At ACCI=0.90, implies Daily carbohydrate intake = 90 % of total daily energy 
expenditure and the rest blood glucose for glucose utilization is covered by the 
conversion of non-carbohydrate (fat and protein) to blood glucose from the body. 
Simulated Results 
 
Figure 6-13. Simulated result of blood glucose concentration under policy A and CICC =0.9. 
 
  
Figure 6-14. Simulated result of fat converted to glucose and glucose from non-carbohydrate nutrients from 
the body under policy A and CICC =0.9. 
 
  




6.3.1.3 Summary for simulated results of both treatments. 
 
Table 6-3. Simulated policy result comparison table.  
Parameter 
Policy A Policy B 
ACCI=1.00 ACCI=0.94 ACCI=0.93 ACCI=0.90 
Last day Morning Blood Glucose 
Concentration(mmol/l) 
7.65 7.65 7.64 7.64 
Total Fat Converted to Glucose(gram) 
0 0 2.14 34.9 
Total non-Carbohydrate converted to 
Glucose(gram) 
0 0 9.53 372 
Last day BMI(Kg/m2) 
26.7 26.7 26.7 26.7 
Last day Body weight (Kg) 
84.8 84.8 84.8 84.8 
  
6.3.1.4 General treatment phase result analysis. 
Total fat goal is calculated from BMI goal since fat is directly proportional to BMI. 
Reference to the simulated result of total fat, fat goal (figure 6-16) and BMI (table 6-4), total fat in 
the body decreases linearly and decreases decreasingly at the end until it reaches fat mass of 34.1 kg 
because daily fat intake rate for 2166 hours as a supplier of fat increases gradually from zero and 
approaches to fat oxidation rate as a source of energy (see figure 6-17).  
 
 
Figure 6-16. Simulated results of total fat and fat goal of the body during the treatment period. 
 
Decreasing of the gap between fat oxidation rate and daily fat intake rate enforces total fat to 
decrease decreasingly at the end, decreasing of total fat influences BMI to decrease by 






Figure 6-17. Simulated result for total oxidized fat and total daily fat intake. 
Therefore, during the treatment phase (3 months stay) body weight/BMI/fat mass of the body 
decreases due to fat oxidation dominance through the balancing loop of B12 over daily fat intake 
through the balancing loop of B18 (see Figure 6-3).  
The gradual reduction of body weight (see table 6-4) or body fat reduces the daily energy 
expenditure since energy expenditure directly proportional to body weight, this implies that the 
amount of glucose used by the cell decreases relative the amount of glucose used by the cell at the 
initial body weight of 103 kg. 
Table 6-4. Weight change percentage of simulated and calculated result.  
3 months treatment change 
Fat Weight BMI Body Weight 
Initial 
(Gram) 























52200 34100 83.02752 34 26.7 81.11111 103 84.8 66.64225 
 
Based on the simulated result in figure 6-7, blood glucose concentration decreases  and reaches 7.65 
mmol/l at the last day of treatment, that means there is an improvement of morning blood glucose 
level from 14.9 mmol/l to 7.65 mmol/l , this indicates that there is an additional physiological 
improvement in the body that drains glucose as a source of energy from the blood vessel because the 
policy proposes daily carbohydrate intake is equal to glucose used by the body.  
Intra-abdominal fat (IAF) reduction due to decreasing of total body weight influences muscle and 
adipose tissues glucose utilization through the reinforcing loops of R3 and R5, this glucose 
utilization multiplying effect in this treatment period shows an improvement from 0.42 to 0.72 for 






Figure 6-18. Simulated result of fat multiplying effect on muscle and adipose tissue glucose utilization. 
So, the effect of body weight reduction on muscle and adipose tissue glucose utilization through the 
reinforcing loop of R3 and R5 together with a daily policy-based carbohydrate intake dominates over 
the rest of the physiological loops to have a morning blood glucose concentration improvement from 
14.9 mmol/l to 7.65 mmol/l.  
6.3.2. Testing blood glucose concentration Phase. 
The participants involved in this procedure did a 3-hour blood glucose concentration test after the 
treatment phase by taking a 75-gram glucose, this procedure helps to see how the progress after 
treatment goes because there is visible change of body weight and blood glucose concentration 
registered at the last day of the treatment phase. 
By using the procedure applied on the participants let us set the changed variables according to the 
simulated result and see how the simulated result behaves relative to the participants real blood 
glucose concentration level. 
Model Setting. 




The model starts to simulate at 7 Since the first sample took at 7 A.M from those 
volunteers after the treatment phase. 
Stop time  
the model ends at 10 since the last sample took from the reference was at 10 A.M. 
Initial Blood glucose in 
gram  
Initial blood glucose in gram =6.95 (blood glucose in gram=6.95 g =blood glucose 
concentration =7.65mmol/l) 
Blood glucose concentration in the model will initialize automatically 7.65 mmol/l 
when initializing blood glucose in gram =6.95 gram since morning blood glucose 
concentration at the last day(t=2167) of the treatment is 7.65 mmol/l. 
Food intake for Blood 
glucose concentration 
test 
75 grams (has taken from the reference) 
Average Body weight  
84.8 kg (taken from the last day of the treatment phase, at t =2167) 
68 
 
Average height  
1.74 m 
Physical Activity level 
Physical activity level is set at the basal level since no need of physical activity 
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Energy expenditure 
Energy Expenditure during the test: energy expenditure is set (PAL=1.4) by 
considering the volunteers are admitted just to take the samples. 
 
6.3.3. Test phase blood glucose concentration behavior result analysis. 
 
Based on a 3-hour testing duration, the simulated result of blood glucose concentration level 
responds to 75 grams of glucose shown in figure 6-19 has three phases. Blood glucose concentration 
decreasing linearly, then increases for one hour and finally decreases for 2 hours, similarly the 
reference mode increases then decreases in the same direction of simulated result with different slope 
and different amplitude but at the beginning both goes in opposite direction. 
Even if both the simulated result and the reference mode go in the same direction for 96% of the time 
horizon, additional methods should apply to see how the model is accurate to reproduce the reference 
mode, the accuracy of the model can be evaluated by using behavior reproduction test through the 
calculation formulated based on simulated and reference mode levels. 
 
Figure 6-19. Simulated and data taken from the participants as a reference result of blood glucose 
concentration. 
Behavior reproduction test in table 6-6 shows that the mean absolute percentage error deviates from 




Table 6-6. Behavior reproduction test table for blood glucose concentration after treatment.  
Behavior reproduction test after treatment 





















7.5 8.8 18.9 
8 11 21.8 
9 11.6 18 
10 10 15.4 
 
6.3.3.1 Analysis of Testing blood glucose concentration. 
Result of testing the blood glucose concentration for 3 hours shown in figure 6-19 indicates that 
model-based simulation decreases linearly for 6 minutes (3% of the time horizon) because glucose 
oxidation rate for 6 minutes is greater than glucose supplied to the blood vessel due to the delay 
during glucose ingestion and reaches its maximum value after 48 minutes since glucose utilization in 
different tissues and organs are less than glucose ingestion rate. 
By following increasing decreasingly for 48 minutes, Blood glucose concentration stays at 
equilibrium at the peak value for 6 minutes because glucose utilized by the cell is equal to glucose 
supplied to blood vessel. 
Following to the equilibrium at the peak value, blood glucose concentration decreases for 2 hours 
due to high amount of glucose used by the cell relative to glucose intake.  
6.4. Summary of weight maintenance treatment effect on the vital tissues of insulin resistance. 
 
Table 6-7. Summary of policy-based treatment improvement table for insulin resistance. 
Summary of data before and After Insulin resistance Treatment. 









14.9 14.9 0 Models’ initial morning blood 
glucose concentration from real data. 
Weight(kg) 103 103 0 Models initial weight from real data. 
BMI (kg/m2) 34 34 0 Models initial BMI from by 
calculating real data of weight and 
height. 
Body fat multiplying 
effect on Adipose tissue 
glucose utilization 
 - 0.42  - Has no given data from participants, 
only from the model based on the 
given body weight 
Body fat multiplying 
effect on Muscle tissue 
 - 0.47  - Has no given data from participants, 
only from the model based on the 
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glucose utilization. given body weight. 






Difference   
Morning Blood 
Glucose(mmol/l). 
7.26 7.65 0.39 There is a little difference between 
real data and the simulated result. 
Weight(kg). 86.1 84.8 1.3 There is 1.3 kg difference between 
the simulated and the real data.  
BMI (kg/m2). 28.7 26.7 2 BMI from the simulated result of 
body weight will be 28 kg/m2. 
Body fat multiplying 
effect on Adipose tissue 
glucose utilization. 
 - 0.72  - There is an improvement relative to 
the initial value. 
Body fat multiplying 
effect on Muscle tissue 
glucose utilization. 
 - 0.74  - There is an improvement relative to 
the initial value. 
 
6.5. Policy evaluation and policy implementation. 
Policy analysis on the previous part provides insight to see the advantage and disadvantage of each 
policy during implementation, advantage and disadvantage of the policy depends on the local 
variable included in this model (CICC) to reach the right goal of curing from Insulin resistance. 
Implications in Policy A. 
The daily intake of carbohydrate is more than enough when CICC is 1 because it is calculated based 
on daily maximum glucose oxidation by the organs in the body but when CICC decreases until 0.93, 
the carbohydrate as daily intake become optimized because as far as human body is under complex 
system, glucose utilization needs hormones that facilitate the process even if enough glucose is 
supplied. This implies if there is no enough amount of hormones in the process of oxidation, 7 % of 
the glucose considered as excess, this daily 7% excess glucose in life long converted to fat and the 
body fall again on the disease related to excess fat rather than being a solution for insulin resistance. 
The advantage of Policy A is no doubt to face a problem related to shortage of blood 
glucose(hypoglycaemia) because at CICC=1 blood glucose concentration become in the intended 
range. 
Implications in policy B. 
The net daily flow between total glucose intake and total glucose oxidation become approaches to 
zero because the daily carbohydrate intake is calculated based on daily glucose oxidation, but if there 
is shortage of blood glucose, body can get enough glucose by converting fat to glucose through the 
process of gluconeogenesis. 
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Therefore, the advantage of policy B is that there is no problem related to excess glucose induced 
diseases in addition to considering body fat as a source of glucose in the daily plan, using body fat as 
glucose contributes body fat reduction. So, in Policy B weight reduction is practiced by using fat as a 
source of energy through fat oxidation and fat as a source of glucose through gluconeogenesis for the 
sack of blood glucose homeostasis. However, the disadvantage of Policy B needs curiosity of each 
minute activity, that means blood glucose and organs are more sensitive if daily plan does not follow 
the policy critically. In case there is any delay of daily activity, blood glucose totally falls in critical 
conditions of hypoglycaemia, this condition further worsen the physiology of the organ because 
Policy B proposes fat conversion to glucose is included in normal basis in addition to daily intake of 
carbohydrate. 
Policy making by considering the basic policy implementation obstacles is better to get rid of the 
problem easily, implementing the designed policy has a lot of obstacles to make it practical on the 
ground. Generally, there may be other policy implications that are important to take into account but 
that are out of the scope of this thesis, such as: people living in different situations (country, culture, 
etc.), people prone to other health related issues, awareness on the health issues, financial status, diet 
habits, and limitations to access physical activity facilities. 
• Other health related issues: To implement the policy being free from other health problems 
would have better effect on weight reduction period since the policy plan needs enough rest 
with long time energy demanding activity. 
• Awareness: Being aware on the complication of insulin resistance and the solution on hand 
is a key point to generate daily motivation to be committed, early aware on the problem 
would be an efficient approach to prevent insulin resistance. 
• Financial status: Shortage of finance on every body’s daily life leads to be away from the 
line recommended policy for the treatment of insulin resistance since working environment 
and load of work varies from place to place. 
• Diet habits: Daily diet mostly based on our finance and interest on the type of food, 
experiencing new policy diet in a short period of time is difficult since the content, test and 
the amount of the food indicates the interest of the user. 
• Accessibility of physical activity infrastructure: Policy based physical activity needs to 
carefully take into account of the exact duration and monitoring activity level and consider 












Chapter 7 .  Conclusion 
7.1. Conclusion. 
Human anatomy and physiology are one of the complex and interesting nature in the world, the level 
of physiological complexity of different organs in the body makes difficult to get the real cause of 
the problem but instead the problem develops other problem on the other organs as a complication 
since human body is an integrated system of organs, insulin resistance is a problem in blood glucose 
homeostasis process. The presented model base studying of blood glucose homeostasis by using a 
system dynamic approach found as relevant and effective way to investigate the underline cause of 
the problem and to find a feasible solution, model building represents each organ function on the role 
of blood glucose homeostasis and its related problems. 
Based on the structure and the generated dynamic behavior of model-based anatomy and physiology 
of adult blood glucose homeostasis, the author addresses and concludes related to the thesis 
objectives as follows. 
1.To explore the main underlying dynamic interactions among variables (hormone, cell, organ, 
and nutrients) and feedback processes involved during blood glucose homeostasis. 
The fundamental hormones in the blood glucose homeostasis are Insulin and Glucagon, both 
produced in the organ Pancreas. Excess of glucose stored as glycogen in the liver and muscle tissues 
by the help of insulin as a stimulator but during hypoglycemia hormone glucagon activates the 
process of converting carbohydrate and non-carbohydrate nutrients found in the body to glucose, 
body fat and protein found in the body are non-carbohydrate sources whereas stored glycogen in 
liver as a carbohydrate source. 
Conversion of excess glucose to fat also occur when muscle storage of glycogen is full, and 
parallelly kidney removes excess blood glucose from the body during filtration. 
Dynamic interaction of organs, hormones in the body explained in the hypothesis part of the thesis in 
detail. 
2.To analyze dynamic effect of body hormones especially insulin on glucose metabolic process 
since less quantity (unproportionable) production of insulin in the body is an indication to the 
disease Diabetics mellitus. 
In reference to the simulated results of insulin production on glucose utilization at 5.2, glucose 
utilization on insulin dependent tissues varies according to the amount of insulin in the body 
especially muscle and adipose tissues. 
When insulin production decreases by half, adipose tissue gets 28.8 % and muscle tissue 20.3% of 
the energy required to keep its normal daily activity, and the rest of muscle and adipose tissues cell 
functionality face a problem. Glucose oxidation on adipose and muscle tissue become worse when 
the production of insulin decreases, and glucose in the blood as a primary complication stay high and 
develops further secondary complications on cardiovascular, kidney and eye in the long run, such 
reduction of insulin production could be an example of specifically Diabetes Mellitus II.  
Insulin production 0 % means pancreas do not produce insulin at all, and this could be an example 
for Diabetes Mellitus type I. In this case Adipose tissue and muscle tissues do not burn glucose to get 
enough energy to carry out its normal daily activity otherwise the body needs external insulin 




3. To study the dynamic implication of insulin resistance development in the body and to 
investigate potential management mechanisms to address insulin resistance.  
As we see from the beginning of identifying the problem as Insulin resistance to the final designed 
and tested policy using the model, morning blood glucose approaches the normal level due to 
coupled policies applied on weight reduction treatment phase since human blood glucose 
homeostasis is concerned. 
Those coupled policies are planned daily activity and daily activity based daily food intake, daily 
food intake takes the highest influential nutrients for the cause of weight gain into consideration, fat 
and carbohydrate are the main nutrients included in the model. 
Based on the final simulation result, fat intake begins from zero at the first date and then increases 
gradually because excess fat in the body can be used as a source of energy during fat oxidation and 
sometimes this fat also uses as glucose through the process of gluconeogenesis since blood glucose 
homeostasis trying to keep the blood glucose level in the normal range by using different 
physiological processes in the body during falling phase of blood glucose concentration. 
Interestingly at the policy, the relation between weight and the daily carbohydrate intake through 
daily energy expenditure decreases the amount of carbohydrate daily intake during weight reduction 
period, this relation during policy making prevents blood vessels from overloaded by excess glucose. 
However, fat and carbohydrates are the vital and the dominant source of energy in the body, protein 
can be taken daily together with simulated fat and carbohydrate because protein do not have that 
much effect to aggravate the problem happened on Insulin resistance. 
During the treatment phase of weight reduction, decreasing weight of fat in the body decreases the 
effect of excess fat on muscle and adipose tissue glucose utilization. Significant change on those 
insulin sensitive tissues recorded during simulation, those weight reduction base changes on 
utilization of glucose is improving the relation between the hormone insulin and the production of 
glucose transporters (GLUT 4) through insulin receptor. 
A healthy relationship between hormone insulin and production of glucose transporters (GLUT 4) 
improves utilization of glucose on muscle and adipose cells, and decreases morning blood glucose 
concentration level, this implies that insulin resistance becomes less, and insulin gets better feedback 
by producing glucose transporter (GLUT 4). 
Therefore, it can be observed that the policy tested in this thesis addresses the problem of insulin 
resistance and gives a better glucose utilization on insulin sensitive tissues by increasing sensitivity 
of cells to insulin and gives intended morning blood glucose concentration through all the processes 
included in blood glucose homeostasis since human blood glucose homeostasis is one of the complex 
systems that exist in nature.  
 
7.2. Limitations and Further work. 
On the presented study there are limitations that can be taken into consideration on future work Since 
during reviewing research, study limitations were confronted usually, limitations found in this study 
and recommendations to modify this thesis on the future work listed as follows. 
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• The level of aggregation in this study is high. The developed model uses fat in general, but it 
needs to differentiate fat into fatty acids and glycerol’s, free fatty acids are a source of energy 
controlled by hormone glucagon. The availability of glycerol is again controlled by the 
hormone glucagon and used as a source of glucose during gluconeogenesis. 
• Boundary extension on future work would be to include other hormones as an endogenous 
and exogenous, endogenous hormone are incretins and somatostatin whereas exogenous 
hormones are Adrenalin, Epinephrine, cortisol, and growth hormone. 
• Gender and age are not included in this model but including gender and age on the future 
work advances the efficiency of the model to generate the adequate results for specific age 
and specific gender. 
• To construct a robust model based on scientific evidence requires more time, blood glucose 
homeostasis-related topics are broad and needs sufficient time to develop and analyse the 
expected result. Therefore, more time and data are needed to add more detailed structure and 
test other possible scenarios and policies. 
• Future work could be done on testing a new policy. Due to the availability of free fatty acid 
in the body, flexible energy source shift from fatty acids to glucose and from glucose to free 
fatty acid happens. This would require a new policy that takes availability of free fatty acid 
into consideration to burn more fat from the body. 
Despite the limitations mentioned above, the model developed in this study helps to understand and 
identify influential factors and feedback processes involved in blood glucose homeostasis 
mechanisms and related problems such as insulin resistance, so that interventions can be identified 
and assessed to reduce and prevent diseases resulting from insulin resistance. The presentation of the 
model behaviour in a scenario and policy space, provides support to employ system dynamics as a 
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Appendix I. Table and figures. 
Table 7-1. Glucose transporters and organs that glucose transporters responsible for. 











GLUT1 Class I Pancreas Beta cells Glucose Non-Insulin 
GLUT2 Class I Pancreas, Liver and Kidney Glucose Non-Insulin 
GLUT3 Class I Mainly Brain Glucose Non-Insulin 
GLUT4 Class I Skeletal Muscle and Adipose Tissue Glucose Insulin 
GLUT5 Class II Small intestine, tests, and kidney Fructose Non-Insulin 
GLUT6 Class III 
Brain, Spleen cells and Peripheral 
leukocytes 
  Non-Insulin 
GLUT7 Class II 





GLUT8 Class III Testis and Brain Glucose Non-Insulin 
GLUT9 Class II Kidney, Liver and Placenta Glucose Non-Insulin 
GLUT10 Class III 
Skeletal Muscle, Lung Tissue, Heart, 
Brain, Placenta, Kidney, Liver and 
Pancreas 
Glucose Non-Insulin 
GLUT11 Class II 
Heart, skeletal muscle, Kidney, Placenta, 




GLUT12 Class III 
Adipose, Small intestine, Skeletal 




can be stimulated 
by Insulin 












Figure 7-2. Diagram glucose as a source of energy through the process of glycolysis, adapted from (Yetkin-





Figure 7-3. Diagram for non-carbohydrate substrates(glycerol as fat and amino acid as protein) in the process 
of gluconeogenesis adapted from (Sanders, 2016). 
 
 




Figure 7-5. Insulin stimulated GLUT4 production adapted from (Ashish et al., 2020). 
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Body Mass Index initialize with the 
initial body weight and takes in to 
account any body weight change every 
hour through Change in BMI. 
 
Body_Fat(t) 











Initialize with the total fat of the body 
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Total glucose excreted out of the body 
due to kidney re-absorption capacity 
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Gastrointestinal_Tract(t - dt) + 
(Ingestion_Rate - 
Glucose_Assimilation_Rate_from







Total accumulated amount of 
carbohydrate accumulated in the 
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Total glucagon in the blood vessel is the 
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(Glucose_to_fat_Convertion_rate
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Total amount of Insulin in the blood 
vessel, initial value of insulin varies 




















calculated from net flow between total 
glucose into the kidney and the rest 
(glucose back to the blood vessel and 
out from the body) 
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(Liver_Glycogenesis_Rate - 
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and proteins 
here is the total amount of glucose 
converted from non-carbohydrate 
sources (Fats and proteins) 
Proteins are in this model considered as 












Choy, S., Hénin, E., van der Walt, J. S., 
Kjellsson, M. C., & Karlsson, M. O. 
(2013). Identification of the primary 
mechanism of action of an insulin 
secretagogue from meal test data in 
healthy volunteers based on an 
integrated glucose-insulin model. 
Journal of pharmacokinetics and 
pharmacodynamics, 40(1), 110 
From the graph average time needed for 
glucose absorption =2.15 hours 
therefore, Assimilation rate of 
88 
 
carbohydrate from the wall intestine is 
















Poudel, R. R. (2013). Renal glucose 
handling in diabetes and sodium glucose 
cotransporter 2 inhibition. Indian journal 
of endocrinology and metabolism, 
17(4), 588. 
Glucose removal rate with urine has 















6- Fialkowski Revilla, M. K., 
Titchenall, A., Calabrese, A., Gibby, C., 
& Meinke, W. (2018). Human Nutrition. 
the flow begins when the glycogen in 
the muscle is reaching max. 
page.232 and 297 
Jensen, J., Rustad, P. I., Kolnes, A. J., & 
Lai, Y. C. (2011). The role of skeletal 
muscle glycogen breakdown for 
regulation of insulin sensitivity by 
exercise. Frontiers in physiology, 2, 112 
*475-gram carbohydrate become 150 g 
lipid/ day. 
Calculation 
conversion rate =475/ (24) =19.79 gram 
per hour =0.3665 mmol/l/minute 
and 3.17g glucose is converted to 1 
gram fat 
1gram glucose =0.316 gram fat 
 
Ingestion_Rate Total_Carbohydrate_intake  
gram/h
our 












Insulin change rate indicates net insulin 
in the blood vessel, includes production 
of Insulin from beta cell of pancreas 





IF Liver_Glycogen < 79 THEN 







Roden, M., Perseghin, G., Petersen, K. 
F., Hwang, J. H., Cline, G. W., Gerow, 
K., ... & Shulman, G. I. (1996). The 
roles of insulin and glucagon in the 
regulation of hepatic glycogen synthesis 
and turnover in humans. The Journal of 
clinical investigation, 97(3), 642-648. 
Glycogen synthesis in the liver taken 
from from figure 3 
the unit is gm/hr, 
when glycogen in the liver is full, no 
more glycogenesis. 
Hers, H. G. (1990). Mechanisms of 
blood glucose homeostasis. Journal of 




the rate is changed from micro mol to 
milli mol and the equilibrium point is at 
the blood glucose is at 5.7 mmol /l this 









Ramnanan, C. J., Edgerton, D. S., Kraft, 
G., & Cherrington, A. D. (2011). 
Physiologic action of glucagon on liver 
glucose metabolism. Diabetes, Obesity 
and Metabolism, 13, 118-125. 











Murray, B., & Rosenbloom, C. (2018). 
Fundamentals of glycogen metabolism 
for coaches and athletes. Nutrition 
reviews, 76(4), 243-259. 
total glucose utilization = the effect of 
fat on utilization*the amount of glucose 
needed from the muscle during physical 
movement since ectopic fat in the 













Murray, B., & Rosenbloom, C. (2018). 
Fundamentals of glycogen metabolism 
for coaches and athletes. Nutrition 
reviews, 76(4), 243-259. 
 
Glycogen synthesis is mediated by the 
hormone insulin and the amount of of 
glycogen synthesis is depends on the 













Bano, G. (2013). Glucose homeostasis, 
obesity and diabetes. Best Practice & 
Research Clinical Obstetrics & 
Gynaecology, 27(5), 715-726. 
 
Glucose utilization grouped in to 6 
tissues in the body.  
this varible inclues kidney, blood cell 
and Splanchnic organs 
kidney is between 10-15% (Avg. 
12.5%) 
blood cells is between 5-10% 
Avg.7.5%),  
Splanchnic organ is between 3-6% 
Avg.4.5%) 
24.5/82.5=0.2969=> 29.69 % of glucose 







Concentration of glucose in the blood 
Calculated from total glucose in gram 
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0  Gram 
Freckmann, G., Hagenlocher, S., 
Baumstark, A., Jendrike, N., Gillen, R. 
C., Rössner, K., & Haug, C. (2007). 
Continuous glucose profiles in healthy 
subjects under everyday life conditions 
and after different meals. Journal of 
diabetes science and technology, 1(5), 
695-703. 
 
50 gram is administered orally 3 times 
daily during testing blood glucose 





0  Grams 
Henry, R. R., Wallace, P., & Olefsky, J. 
M. (1986). Effects of weight loss on 
mechanisms of hyperglycemia in obese 
non-insulin-dependent diabetes melli-
tus. Diabetes, 35(9), 990-998. 
 
75 gram of glucose is administered 
orally to measure blood glucose 
concentration in the morning both 





entration\"") Points: (0.00, 1.5), 
(3.30, 1.5), (6.60, 3.0), (9.90, 
5.0), (13.20, 7.5), (16.50, 10.5), 
(19.80, 50.0), (23.10, 80.0), 





Hall, J. E., & Hall, M. E. (2020). 
Guyton and Hall textbook of medical 
physiology e-Book. Elsevier Health 
Sciences. 
 


























Freckmann, G., Hagenlocher, S., 
Baumstark, A., Jendrike, N., Gillen, R. 
C., Rössner, K., & Haug, C. (2007). 
Continuous glucose profiles in healthy 
subjects under everyday life conditions 
and after different meals. Journal of 
diabetes science and technology, 1(5), 
695-703. 
(BMI) 22.6 ± 1.7 kg/m2] ~ 23 kg/m2  
Assume height = 1.74 because height is 
not given, took from the previous 
reference mode. 
=> weight = 1.74*1.74 *23 = 69.63 ~ 70 
kg 
 
remember initializing blood glucose in 












United Nations University, & World 
Health Organization. (2004). Human 
Energy Requirements: Report of a Joint 
FAO/WHO/UNU Expert Consultation: 
Rome, 17-24 October 2001 (Vol. 1). 
Food & Agriculture Org. 
Total BMR by taking whole body 
weight under consideration 
=> Average BMR per day 
=("Average_BMR/Kg") * 
(Body_Waight) 





(45.00, 25.50), (50.00, 24.75), 
(55.00, 23.50), (60.00, 22.50), 
(65.00, 21.50), (70.00, 20.50), 
(75.00, 20.00), (80.00, 19.25), 




United Nations University, & World 
Health Organization. (2004). Human 
Energy Requirements: Report of a Joint 
FAO/WHO/UNU Expert Consultation: 
Rome, 17-24 October 2001 (Vol. 1). 
Food & Agriculture Org. 
Basal metabolism rate (BMR) is the 
minimum energy required by our body 
per kg of body weight 
the graph here is the average for 
men,women in two different age groups 
(30-59.9 and greater than 60 years both 




103  Kg 
1.for Insulin resistance participants 
Weight =103 kg 
2.Freckmann, G., Hagenlocher, S., 
Baumstark, A., Jendrike, N., Gillen, R. 
C., Rössner, K., & Haug, C. (2007). 
Continuous glucose profiles in healthy 
subjects under everyday life conditions 
and after different meals. Journal of 
diabetes science and technology, 1(5), 
695-703. 
(BMI) 22.6 ± 1.7 kg/m2] ~ 23 kg/m2  
Assume height = 1.74 because height is 
not given, took from the previous 
reference mode. 
=> weight = 1.74*1.74 *23 = 69.63 ~ 70 
kg 
remember initializing blood glucose in 
gram = 3.9 gram (has taken from the 
reference above) 









AF_Effect) Points: (0.000, 
0.000), (0.100, 0.33583091167), 
(0.200, 0.560945103841), (0.300, 
 
unitless 
The effect of insulin to produce glucose 
transporter increases during reduction of 
















24*INT(TIME/24)  Hr 







IF TIME < 31THEN 0 ELSE 
24*(1+INT ((TIME-31)/24)) 
 Hr 
To generate a cyclic clock for time 
between 24-31 because simulation starts 







Daily fat intake is total amount of fat 







one day is 24 hours, in this variable one 





GRAPH(BMI) Points: (15.00, 
17.00), (20.00, 27.50), (25.00, 
37.50), (30.00, 45.50), (35.00, 





Meeuwsen, S., Horgan, G. W., & Elia, 
M. (2010). The relationship between 
BMI and percent body fat, measured by 
bioelectrical impedance, in a large adult 
sample is curvilinear and influenced by 
age and sex. Clinical nutrition, 29(5), 
560-566. 
From the graph, as BMI increases body 





GRAPH(BMI) Points: (24.30, 













Ferrannini, E., Sironi, A. M., Iozzo, P., 
& Gastaldelli, A. (2008). Intra-
abdominal adiposity, abdominal obesity, 
and cardiometabolic risk. European 
heart journal supplements, 10(suppl_B), 
B4-B10.:- 
there is a difference between man and 
women intra abodminal fat/Visceral 
Adipose Tissue (IAF or VAT ) based on 
BMI but now average is taken from the 







Points: (0.2000, 0.000), (0.4500, 





Ramnanan, C. J., Edgerton, D. S., Kraft, 
G., & Cherrington, A. D. (2011). 
Physiologic action of glucagon on liver 
glucose metabolism. Diabetes, Obesity 
and Metabolism, 13, 118-125. 








Virtanen, K. A., Iozzo, P., Hällsten, K., 
Huupponen, R., Parkkola, R., 
Janatuinen, T., ... & Knuuti, J. (2005). 
Increased fat mass compensates for 
insulin resistance in abdominal obesity 
and type 2 diabetes: a positron-emitting 
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tomography study. Diabetes, 54(9), 
2720-2726 
the graph or the formula found on the 
above reference shows that as the intra-
abdominal fat (IAF) increases the 








Ferrannini, E., Sironi, A. M., Iozzo, P., 
& Gastaldelli, A. (2008). Intra-
abdominal adiposity, abdominal obesity, 
and cardiometabolic risk. European 
heart journal supplements, 10(suppl_B), 
B4-B10 
Muscle Glucose uptake decreases as 
Intra-abdominal fat (IAF) increases 











0.26894142137), (0.500, 0.500), 








Rizza, R. A., Mandarino, L. J., & 
Gerich, J. E. (1981). Dose-response 
characteristics for effects of insulin on 
production and utilization of glucose in 
man. American Journal of Physiology-
Endocrinology And Metabolism, 
240(6), E630-E639. 
on Fig 3 as Insulin concentration 
increases Glucose utilization follows an 
S shape, here the effect is running 
between 0 and 1 since glucose 






GRAPH(PAL) Points: (1.4000, 
25.00), (1.4590, 31.50), (1.5180, 
38.00), (1.5770, 44.50), (1.6360, 
51.00), (1.6950, 57.50), (1.7540, 
64.00), (1.8130, 70.50), (1.8720, 





Burton, D. A., Stokes, K., & Hall, G. M. 
(2004). Physiological effects of 
exercise. Continuing Education in 
Anaesthesia Critical Care & Pain, 4(6), 
185-188. 
Vo2 % increases as working rate 
increases=> %Vo2 proportion to 



























Holloszy, J. O., Kohrt, W. M., & 
Hansen, P. A. (1998). The regula-tion of 
carbohydrate and fat metabolism during 
and after exer-cise. Front Biosci, 3, 
D1011-D1027 
 
Calculate the Carbohydrate share as a 
function of % Vo2  
40-100% Vo2 max 
and %Vo2 max less than 40 % is 
described on the paragraph next to 
figure 1. 
 




























share of fat demand increases as % Vo2 
max decreases 
 
2. (Wolfe, R. R. (1998). Metabolic 
interactions between glucose and fatty 
acids in humans. The American journal 
of clinical nutrition, 67(3), 519S-526S. 
 
Calculate the carbohydrate and fat share 





Points: (17.00, 15.00), (27.50, 
20.00), (37.50, 25.00), (45.50, 
30.00), (52.00, 35.00), (57.50, 





Ferrannini, E., Sironi, A. M., Iozzo, P., 
& Gastaldelli, A. (2008). Intra-
abdominal adiposity, abdominal obesity, 
and cardiometabolic risk. European 
heart journal supplements, 10(suppl_B), 
B4-B10.:- 








Fat free mass = Total mass (Total body 












Calculation of fat share from total 

























Freckmann, G., Hagenlocher, S., 
Baumstark, A., Jendrike, N., Gillen, R. 
C., Rössner, K., & Haug, C. (2007). 
Continuous glucose profiles in healthy 















and after different meals. Journal of 
diabetes science and technology, 1(5), 
695-703. 
 
50 gram is administered orally 3 times 
daily during testing blood glucose 





entration\"") Points: (0.00, 100.0), 













Hall, J. E., & Hall, M. E. (2020). 
Guyton and Hall textbook of medical 
physiology e-Book. Elsevier Health 
Sciences. 
 
Took from FIGURE 79-10, glucagon 















Bano, G. (2013). Glucose homeostasis, 
obesity and diabetes. Best Practice & 
Research Clinical Obstetrics & 
Gynaecology, 27(5), 715-726. 
Glucose utilization grouped in to 6 
tissues in the body.  
Brain between 45-60 %(Avg.52.5%), 
skeletal muscle between 15-20% 
Avg.17.5%), 
kidney between 10-15% (Avg. 12.5%) 
blood cells between 5-10% Avg.7.5%),  
Splanchnic organ between 3-6% 
Avg.4.5%),  
and Adipose tissue 2-4% Avg.3%), 
 
Muscle share is 17.5 and then the rest 








Riemsma, R., Ramos, I. C., Birnie, R., 
Büyükkaramikli, N., Armstrong, N., 
Ryder, S., ... & Kleijnen, J. (2016). 
Integrated sensor-augmented pump 
therapy systems [the MiniMed® 
Paradigm™ Veo system and the Vibe™ 
and G4® PLATINUM CGM 
(continuous glucose monitoring) 
system] for managing blood glucose 
levels in type 1 diabetes: a systematic 
96 
 
review and economic evaluation. Health 
technology assessment (Winchester, 
England), 20(17), 1. 
Appendix 5 table 86 
1 mg/dl =18.18*mmol/l  



















Bano, G. (2013). Glucose homeostasis, 
obesity and diabetes. Best Practice & 
Research Clinical Obstetrics & 
Gynaecology, 27(5), 715-726. 
Glucose utilization grouped in to 6 
tissues in the body., one of the tissues is 
adipose tissues  
Average from the total glucose 
utilization is 3% but now glucose is 
deducted to skeletal muscles then 
Adipose tissue share is 








Bano, G. (2013). Glucose homeostasis, 
obesity and diabetes. Best Practice & 
Research Clinical Obstetrics & 
Gynaecology, 27(5), 715-726. 
Glucose utilization grouped in to 6 
tissues in the body.  
These include the brain 45-60 % (55% 
taken from the rest of the tissues) of the 
total  
but now the remaining glucose is 
calculated from the remaining value of 
glucose used by the muscle 










Bano, G. (2013). Glucose homeostasis, 
obesity and diabetes. Best Practice & 
Research Clinical Obstetrics & 
Gynaecology, 27(5), 715-726. 
Glucose utilization grouped in to 6 
tissues in the body.  
this varible inclues kidney, blood cell 
and Splanchnic organs 
kidney is between 10-15% (Avg. 
12.5%) 
blood cells is between 5-10% 
Avg.7.5%),  
Splanchnic organ is between 3-6% 
Avg.4.5%) 
24.5/82.5=0.2969=> 29.69 % of glucose 
is for Splanchnic Organs. 
 









obesity and diabetes. Best Practice & 
Research Clinical Obstetrics & 
Gynaecology, 27(5), 715-726. 
Muscle is using Glycogen as a glucose, 
glucose utilized by the muscle is 15-







Murray, B., & Rosenbloom, C. (2018). 
Fundamentals of glycogen metabolism 
for coaches and athletes. Nutrition 
reviews, 76(4), 243-259. 
during usage of glucose by muscle, the 
glycogen level will decrease in the 
Muscle storage  











Bano, G. (2013). Glucose homeostasis, 
obesity and diabetes. Best Practice & 
Research Clinical Obstetrics & 
Gynaecology, 27(5), 715-726. 
Muscle is using Glycogen as a glucose, 
glucose utilized by the muscle is 15-
20% of the total glucose  
average =17.5% 
and the unit is changed to gram /hour. 
 










Height 1.74  meter  
 




Delay is 1 hour since our daily activity 













entration\"") Points: (0.00, 100.0), 













This variable is only to initialize the 
Glucagon stock in the body since we 
have initial value of blood glucose. 
Hall, J. E., & Hall, M. E. (2020). 
Guyton and Hall textbook of medical 
physiology e-Book. Elsevier Health 
Sciences. 







entration\"") Points: (0.00, 1.5), 
(3.30, 1.5), (6.60, 3.0), (9.90, 
5.0), (13.20, 7.5), (16.50, 10.5), 
(19.80, 50.0), (23.10, 80.0), 





This variable is only to initialize the 
insulin stock in the body since we have 
initial value of blood glucose. 
Hall, J. E., & Hall, M. E. (2020). 
Guyton and Hall textbook of medical 
physiology e-Book. Elsevier Health 
Sciences. 





entration\"") Points: (5.000, 0.00), 
(5.500, 40.00), (6.000, 80.00) 
 
Gram 
liver glycogen begins to decrease when 
there is low amount of glucose in the 
blood vessel, and when blood glucose is 








Insulin production test is normally 1 
but we can vary to see different senario 
by varying from 0 to 1, 
* 1 means pancreas produces 100% 
...normal person. 
* 0.5 means pancreas produces 
50%....has problem on pancreas 
productivity example diabetic type 2. 
* 0 means pancreas do not work 







Tirone, T. A., & Brunicardi, F. C. 
(2001). Overview of glucose regulation. 
World journal of surgery, 25(4), 461. 







Tirone, T. A., & Brunicardi, F. C. 
(2001). Overview of glucose regulation. 
World journal of surgery, 25(4), 461. 
one gram Carbohydrate gives 4 Kcal 
energy. 
 
kg_to_gram 1000  
grams/k
g 








Roden, M., Perseghin, G., Petersen, K. 
F., Hwang, J. H., Cline, G. W., Gerow, 
K., ... & Shulman, G. I. (1996). The 
roles of insulin and glucagon in the 
regulation of hepatic glycogen synthesis 
and turnover in humans. The Journal of 
clinical investigation, 97(3), 642-648. 
Glycogen synthesis in the liver taken 
from from figure 3 
the unit is changed from mmol/l/hr to 
gm/hr. 






Points: (4.00, 0.00), (4.10, 4.30), 
(5.60, 4.50), (7.20, 5.40), (8.40, 
9.60), (10.60, 24.00), (11.20, 




1.Roden, M., Perseghin, G., Petersen, K. 
F., Hwang, J. H., Cline, G. W., Gerow, 
K., ... & Shulman, G. I. (1996). The 
roles of insulin and glucagon in the 
regulation of hepatic glycogen synthesis 
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and turnover in humans. The Journal of 
clinical investigation, 97(3), 642-648. 
Glycogen synthesis in the liver have 





300  Gram 
1. Murray, B., & Rosenbloom, C. 
(2018). Fundamentals of glycogen 
metabolism for coaches and athletes. 
Nutrition reviews, 76(4), 243-259. 
the normal muscle glycogen storage is 
300-700 gram 
now in this model we are considering 




















Difference between total 
Gluconeogenesis rate- Fat share on 
Gluconeogenesis, 
Non-fat means from protein and others 
converted to glucose when less blood 










The value varies from 0 to 1 to simplify 














Making simplified for calculation 
purpose, the variable run between 0 and 
1. 
 
PAL 1.4  
Dimens
ionless 
United Nations University, & World 
Health Organization. (2004). Human 
Energy Requirements: Report of a Joint 
FAO/WHO/UNU Expert Consultation: 
Rome, 17-24 October 2001 (Vol. 1). 
Food & Agriculture Org. 
" 
PAL = Physical activity level 
1.Sedentary or light activity lifestyle 
(1.40-1.69=PAL value). 
2. Active or moderately active lifestyle 
(1.70-1.99=PAL value). 










1.Choy, S., Hénin, E., van der Walt, J. 
S., Kjellsson, M. C., & Karlsson, M. O. 
100 
 
ke 0) (2013). Identification of the primary 
mechanism of action of an insulin 
secretagogue from meal test data in 
healthy volunteers based on an 
integrated glucose-insulin model. 
Journal of pharmacokinetics and 
pharmacodynamics, 40(1), 1-10. 
Carbohydrate delay in the 
gastrointestinal tract varies from 45-90 
minutes due to digestion due to 
digestion of complex carbohydrates. 
























Henry, R. R., Wallace, P., & Olefsky, J. 
M. (1986). Effects of weight loss on 
mechanisms of hyperglycemia in obese 
non-insulin-dependent diabetes melli-
tus. Diabetes, 35(9), 990-998. 
Blood glucose concentration is changed 













Henry, R. R., Wallace, P., & Olefsky, J. 
M. (1986). Effects of weight loss on 
mechanisms of hyperglycemia in obese 
non-insulin-dependent diabetes melli-
tus. Diabetes, 35(9), 990-998. 
Blood glucose concentration is changed 




















Henry, R. R., Wallace, P., & Olefsky, J. 
M. (1986). Effects of weight loss on 
mechanisms of hyperglycemia in obese 
non-insulin-dependent diabetes melli-
tus. Diabetes, 35(9), 990-998. 
75 gram of glucose is administered 
orally to measure blood glucose 
concentration in the morning both 





duction_per_kg) Points: (0.0000, 
0.000), (0.0900, 0.000), (0.1000, 





1.Rothman, D. L., Magnusson, I., Katz, 
L. D., Shulman, R. G., & Shulman, G. I. 
(1991). Quantitation of hepatic 
glycogenolysis and gluconeogenesis in 
fasting humans with 13C NMR. 
Science, 254(5031), 573-576. 
share of Gluconeogenesis on total 
glucose production 
According to the journal 
gluconeogenesis at 22 hours fasting is 
101 
 
64 %,36 hours is 82% and 54 hours 96 
% of glucose is from gluconeogenesis.  












Chourpiliadis, C., & Mohiuddin, S. S. 
(2020). Biochemistry, gluconeogenesis. 
StatPearls [Internet]. 












Start_Time 7  Hour  
 














































United Nations University, & World 
Health Organization. (2004). Human 
Energy Requirements: Report of a Joint 
FAO/WHO/UNU Expert Consultation: 
Rome, 17-24 October 2001 (Vol. 1). 
Food & Agriculture Org. 
Sedentary or light activity life style 
scheduled as follows 
1.Sleeping..8 hour...21.92% 




5.Sitting(Office work, selling, produce, 
tending shop)...8 hour...32.88% 
6.General household work...1 
hour...7.67% 
7.Driving car to/from work...1 
hour...5.48% 
8.Walking at varying paces without a 
load...1 hour...8.77% 


















































0.3  Hr 
Hall, J. E., & Hall, M. E. (2020). 
Guyton and Hall textbook of medical 
physiology e-Book. Elsevier Health 
Sciences. 
Glucagon hormone make change on 






24  Hr 
Murray, B., & Rosenbloom, C. (2018). 
Fundamentals of glycogen metabolism 
for coaches and athletes. Nutrition 
reviews, 76(4), 243-259. 
time require for resynthesis of Glycogen 





0.5  Hr 
1.Fu, Z., R Gilbert, E., & Liu, D. 
(2013). Regulation of insulin synthesis 
and secretion and pancreatic Beta-cell 
dysfunction in diabetes. Current 
diabetes reviews, 9(1), 25-53. 
Insulin fully reaches to blood stream 30 
minutes 
Basal insulin =20-30 pmol/l and delay 
30 min 






1  Hour 






1  Hours 









2.15  Hours 
 
Choy, S., Hénin, E., van der Walt, J. S., 
Kjellsson, M. C., & Karlsson, M. O. 
(2013). Identification of the primary 
mechanism of action of an insulin 
secretagogue from meal test data in 
healthy volunteers based on an 
integrated glucose-insulin model. 
Journal of pharmacokinetics and 
pharmacodynamics, 40(1), 110 
From the graph average time needed for 








5  Liters 
Sani, M. H., & Khosroabadi, S. (2020). 
A novel design and analysis of high-
sensitivity biosensor based on nano-
cavity for detection of blood 
component, diabetes, cancer and 
glucose concentration. IEEE Sensors 
Journal, 20(13), 7161-7168. 




















United Nations University, & World 
Health Organization. (2004). Human 
Energy Requirements: Report of a Joint 
FAO/WHO/UNU Expert Consultation: 
Rome, 17-24 October 2001 (Vol. 1). 
Food & Agriculture Org. 
Total Energy required per day:the daily 
required amount of energy depending on 
the type of physical activity  
PAL*Average_BMR_per_Day = total 
energy Expenditure 
 







Total fat = fat in the body + daily fat 
intake + fat from glucose. 
 













Points: (0.0, 0.0000), (70.0, 
0.0000), (80.0, 0.0420), (95.0, 




Rizza, R. A., Mandarino, L. J., & 
Gerich, J. E. (1981). Dose-response 
characteristics for effects of insulin on 
production and utilization of glucose in 
man. American Journal of Physiology-
Endocrinology And Metabolism, 
240(6), E630-E639. 
on Fig 3. it is as a function of insulin but 
changed to as a function of glucagon 
concentration since Insulin and 
Glucagon inversely proportional 
















0.316  unitless 
Jensen, J., Rustad, P. I., Kolnes, A. J., & 
Lai, Y. C. (2011). The role of skeletal 
muscle glycogen breakdown for 
regulation of insulin sensitivity by 
exercise. Frontiers in physiology, 2, 112 
*475 gram converted to 150 g lipid/ day 
Calculation 
conversion rate =475/ (24) =19.79 gram 
per hour =0.3665 mmol/l/minute 
and 3.17g glucose is converted to 1 
gram fat 





Desired_intake_Glucose(t - dt) + 
(Glucose_required_Rate - 








Desired intake glucose is the total 
glucose required by the cell,  
the initial value for the first day is given 
because glucose as energy requirement 
is every seconds demand since all the 
cells need enough glucose, on the other 
hand the policy is designed to have a 
diet three times a day( that means we 
cannot get instantaneously the amount 
of glucose that the body used) , there for 
in order to calculate the total energy, the 
first day is initialized by some amount 
of glucose but for the next day the 
model by itself calculates the amount of 










Glucose removal rate is taking out all 
amount of glucose requested by the cell 
(before 24 hours of the stock desired 
intake glucose) in order to calculate 








Policy based total required glucose rate 







the gap we want to adjust each hour 
((1/3 due to the adt. rate)  
hourly gap adj fraction, each hour the 
gap closes the goal a minimum of 15%, 
when the fat oxidation is grater, the gap 
approaches the goal more than 15%. 
 
BMI_Goal 25  kg/m2 
BMI Goal is 25 kg/m2 since 25 is the 
upper limit of healthy BMI (kg/m2) 
healthy BMI ≤ 25,  
overweight between 25 and 35. 
obese BMI ≥ 35. 
Hasan, N. M., Johnson, K. F., Yin, J., 
Baetz, N. W., Fayad, L., Sherman, V., . . 
. Zachos, N. C. (2021). Intestinal stem 
cell-derived enteroids from morbidly 
obese patients preserve obesity-related 
phenotypes: Elevated glucose 
absorption and gluconeogenesis. 









Breakfast is at 7.5 hour (7:30 A.M in the 
morning every day) 
 
Breakfast_1 1/5  unitless 
Henry, R., Wallace, P., & Olefsky, J. 
(1986). Effects of weight loss on 
mechanisms of hyperglycemia in obese 
non-insulin-dependent diabetes mellitus. 
Diabetes, 35(9), 990-998.  
Given (1/5=0.2) 
from the daily consumption of 









Daily carbohydrate intake= 
(Carbohydrate intake calibration 
coefficient) * (Total daily energy 
expenditure)  
where, Carbohydrate intake calibration 
coefficient (CICC) shows how much 
(percentage or it can be between 0 and 
1) is the daily carbohydrate intake 









24*INT(TIME/24)  Hour 












Desired hourly carbohydrate intake 
relies on the type of Policy following 
(Policy A or Policy B) by varying 









Recommended glucose amount during 









Breakfast is at 19 hours (7:00 P.M in the 
evening every day ).  
 
Dinner_1 2/5  unitless 
Henry, R., Wallace, P., & Olefsky, J. 
(1986). Effects of weight loss on 
mechanisms of hyperglycemia in obese 
non-insulin-dependent diabetes mellitus. 
Diabetes, 35(9), 990-998.  
Given (2/5=0.4) 
from the daily consumption of 






(15.00, 17.00), (20.00, 22.21), 
(25.00, 29.54), (30.00, 37.84), 





Reference:Meeuwsen, S., Horgan, G. 
W., & Elia, M. (2010). The relationship 
between BMI and percent body fat, 
measured by bioelectrical impedance, in 
a large adult sample is curvilinear and 
influenced by age and sex. Clinical 
nutrition, 29(5), 560-566. 
From the graph, as BMI increases body 





















The difference between the actual fat 








30.4 kg =30400 gram =>  
healthy BMI maximum value is 25 












Lunch_1 2/5  unitless 
Henry, R., Wallace, P., & Olefsky, J. 
(1986). Effects of weight loss on 
mechanisms of hyperglycemia in obese 
non-insulin-dependent diabetes mellitus. 
Diabetes, 35(9), 990-998.  
Given (2/5=0.4) 
from the daily consumption of 




24  Hour 
One day duration is designed to take out 
the amount of glucose required by the 
body the day before yesterday, that 
means in desired intake glucose intake 














7  Hour  
 
policy_status 
IF policy_switch = 1 AND TIME 






policy_switch 0  
Dimens
ionless 
Policy switch become 1 when policy is 
on and 0 when policy is off. 
 




Start Time Explanatory Model.Start Time 
Stop Time Explanatory Model.Stop time 
DT 1/10 
Fractional DT True 
Save Interval 0.1 
Sim Duration 1.5 
Time Units Hour 
Pause Interval 0 
Integration Method Euler 
Keep all variable results True 
Run By Run 
108 
 
Calculate loop dominance information True 
Exhaustive Search Threshold 1000 
 
Array Dimension Indexed by Elements 
PAL_Exostive Number 1 
PAL_Moderate Number 1 
PAL_Sedentary Number 1 
 
 
 
 
 
 
 
 
 
 
 
